<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">94930</article-id><article-id pub-id-type="doi">10.7554/eLife.94930</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.94930.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Rab10 regulates neuropeptide release by maintaining Ca<sup>2+</sup> homeostasis and protein synthesis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dong</surname><given-names>Jian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0002-5201-0748</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Mian</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>van Weering</surname><given-names>Jan RT</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5259-4945</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Ka Wan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6983-5055</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Smit</surname><given-names>August B</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Toonen</surname><given-names>Ruud F</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9900-4233</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Verhage</surname><given-names>Matthijs</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6085-7503</contrib-id><email>matthijs@cncr.vu.nl</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/008xxew50</institution-id><institution>Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit (VU) Amsterdam</institution></institution-wrap><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/008xxew50</institution-id><institution>Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit (VU) Amsterdam</institution></institution-wrap><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05grdyy37</institution-id><institution>Department of Clinical Genetics, Center for Neurogenomics and Cognitive Research (CNCR), University Medical Center Amsterdam</institution></institution-wrap><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Verstreken</surname><given-names>Patrik</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05f950310</institution-id><institution>KU Leuven</institution></institution-wrap><country>Belgium</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>James</surname><given-names>David E</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0384j8v12</institution-id><institution>University of Sydney</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>02</day><month>04</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP94930</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-01-02"><day>02</day><month>01</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-01-02"><day>02</day><month>01</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.01.02.573873"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-03-19"><day>19</day><month>03</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.94930.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-01-06"><day>06</day><month>01</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.94930.2"/></event></pub-history><permissions><copyright-statement>© 2024, Dong et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Dong et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-94930-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-94930-figures-v1.pdf"/><related-article related-article-type="commentary" ext-link-type="doi" xlink:href="10.7554/eLife.106553" id="ra1"/><abstract><p>Dense core vesicles (DCVs) transport and release various neuropeptides and neurotrophins that control diverse brain functions, but the DCV secretory pathway remains poorly understood. Here, we tested a prediction emerging from invertebrate studies about the crucial role of the intracellular trafficking GTPase Rab10, by assessing DCV exocytosis at single-cell resolution upon acute Rab10 depletion in mature mouse hippocampal neurons, to circumvent potential confounding effects of Rab10’s established role in neurite outgrowth. We observed a significant inhibition of DCV exocytosis in Rab10-depleted neurons, whereas synaptic vesicle exocytosis was unaffected. However, rather than a direct involvement in DCV trafficking, this effect was attributed to two ER-dependent processes, ER-regulated intracellular Ca<sup>2+</sup> dynamics, and protein synthesis. Gene Ontology analysis of differentially expressed proteins upon Rab10 depletion identified substantial alterations in synaptic and ER/ribosomal proteins, including the Ca<sup>2+</sup> pump SERCA2. In addition, ER morphology and dynamics were altered, ER Ca<sup>2+</sup> levels were depleted, and Ca<sup>2+</sup> homeostasis was impaired in Rab10-depleted neurons. However, Ca<sup>2+</sup> entry using a Ca<sup>2+</sup> ionophore still triggered less DCV exocytosis. Instead, leucine supplementation, which enhances protein synthesis, largely rescued DCV exocytosis deficiency. We conclude that Rab10 is required for neuropeptide release by maintaining Ca<sup>2+</sup> dynamics and regulating protein synthesis. Furthermore, DCV exocytosis appeared more dependent on (acute) protein synthesis than synaptic vesicle exocytosis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>neuropeptide</kwd><kwd>exocytosis</kwd><kwd>Rab10</kwd><kwd>protein synthesis</kwd><kwd>ER</kwd><kwd>synaptic transmission</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>322966</award-id><principal-award-recipient><name><surname>Verhage</surname><given-names>Matthijs</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020 Framework Programme</institution></institution-wrap></funding-source><award-id>667301</award-id><principal-award-recipient><name><surname>Verhage</surname><given-names>Matthijs</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100031366</institution-id><institution>ERA-Net NEURON</institution></institution-wrap></funding-source><award-id>JPND Neuron Cofund ERA-Net SNAREopathy</award-id><principal-award-recipient><name><surname>Toonen</surname><given-names>Ruud F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Rab10 deficiency unexpectedly inhibits neuropeptide secretion through two distinct effects on the endoplasmic reticulum (ER), disrupting ER-regulated intracellular Ca²⁺ dynamics and impairing protein synthesis.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Dense core vesicles (DCVs) transport and release neuromodulators (neuropeptides, neurotrophic factors, and catecholamines) that play crucial roles in modulating diverse brain functions, including sleep, mood, memory, and learning (e.g. <xref ref-type="bibr" rid="bib13">Cawley et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Malva et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Poo, 2001</xref>; <xref ref-type="bibr" rid="bib59">Salio et al., 2006</xref>). Deficits in neuropeptide signaling pathways have been associated with several human disorders and diseases, including anxiety, depression, and obesity (<xref ref-type="bibr" rid="bib9">Beck, 2000</xref>; <xref ref-type="bibr" rid="bib58">Sah and Geracioti, 2013</xref>; <xref ref-type="bibr" rid="bib8">Barde et al., 2022</xref>). Neuropeptides are synthesized in the endoplasmic reticulum (ER) and subsequently packaged into immature DCVs in the Golgi complex (<xref ref-type="bibr" rid="bib72">Tooze et al., 2001</xref>). DCVs are transported along the neurites and undergo activity-dependent membrane fusion with the plasma membrane to release their content (<xref ref-type="bibr" rid="bib24">Farina et al., 2015</xref>; <xref ref-type="bibr" rid="bib32">Heidelberger et al., 1994</xref>; <xref ref-type="bibr" rid="bib52">Nassal et al., 2022</xref>; <xref ref-type="bibr" rid="bib71">Thomas et al., 1993</xref>; <xref ref-type="bibr" rid="bib74">van de Bospoort et al., 2012</xref>). Despite the critical role of neuropeptides in brain functions, the regulatory mechanisms governing their secretion are not fully understood. We have shown previously that Rab3 is an essential regulator in the last steps of the DCV secretory pathway in mammalian neurons (<xref ref-type="bibr" rid="bib56">Persoon et al., 2019</xref>). However, studies in invertebrates have also implicated other Rab proteins, including Rab2, Rab5, and Rab10, in the DCV secretory pathway (<xref ref-type="bibr" rid="bib2">Ailion et al., 2014</xref>; <xref ref-type="bibr" rid="bib6">Azouz et al., 2014</xref>; <xref ref-type="bibr" rid="bib20">Edwards et al., 2009</xref>; <xref ref-type="bibr" rid="bib30">Hannemann et al., 2012</xref>; <xref ref-type="bibr" rid="bib44">Lund et al., 2020</xref>; <xref ref-type="bibr" rid="bib61">Sasidharan et al., 2012</xref>; <xref ref-type="bibr" rid="bib67">Sumakovic et al., 2009</xref>).</p><p>Among these Rab proteins, Rab10 deficiency produces the strongest inhibition of neuropeptide release in <italic>Caenorhabditis elegans</italic> (<xref ref-type="bibr" rid="bib61">Sasidharan et al., 2012</xref>). With its subcellular localization in many vesicular organelles, such as plasmalemmal precursor vesicles, GLUT4 transport vesicles, and recycling endosomes, Rab10 regulates various aspects of intracellular membrane trafficking, including vesicle formation, transport, and fusion (<xref ref-type="bibr" rid="bib14">Chen et al., 2006</xref>; <xref ref-type="bibr" rid="bib41">Larance et al., 2005</xref>; <xref ref-type="bibr" rid="bib47">Mîinea et al., 2005</xref>; <xref ref-type="bibr" rid="bib60">Sano et al., 2007</xref>; <xref ref-type="bibr" rid="bib70">Taylor et al., 2015</xref>). Rab10 deficiency leads to deficits in these pathways, resulting in impaired neuronal outgrowth and disrupted retrograde axonal transport of signaling factors (<xref ref-type="bibr" rid="bib43">Lazo and Schiavo, 2023</xref>). How these deficits relate to the strong inhibition of DCV exocytosis remains unknown.</p><p>Deletion of Rab10 expression or inhibiting its functions by overexpression of an inactive mutant (Rab10T23N) leads to abnormal ER morphology (<xref ref-type="bibr" rid="bib23">English and Voeltz, 2013</xref>; <xref ref-type="bibr" rid="bib45">Lv et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Shih and Hsueh, 2016</xref>). Since the ER is a crucial organelle involved in protein synthesis, Ca<sup>2+</sup> buffering, and lipid metabolism, alterations in its structure and function can directly or indirectly affect neuronal secretory pathways. Indeed, several studies have suggested the roles of the ER in the DCV pathway, such as the involvement of ER stress and lipid levels in DCV production in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib42">Laurent et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Valadas et al., 2018</xref>), and the roles of ER Ca<sup>2+</sup> as an internal Ca<sup>2+</sup> source regulating somatodendritic dopamine release in mouse substantia nigra neurons (<xref ref-type="bibr" rid="bib53">Patel et al., 2009</xref>). Additionally, Rab10 mutations, altered expression levels, or phosphorylation states are firmly associated with CNS disorders (<xref ref-type="bibr" rid="bib1">Agola et al., 2011</xref>; <xref ref-type="bibr" rid="bib15">Cheng et al., 2005</xref>; <xref ref-type="bibr" rid="bib37">Kiral et al., 2018</xref>). Hence, the strong inhibition of neuropeptide accumulation in coelomocytes in nematode Rab10 mutants may be a direct or indirect effect of Rab10 loss of function on DCV exocytosis and Rab10-dependent disease processes may (in part) be explained by DCV exocytosis impairment.</p><p>In the present study, we investigated the involvement of Rab10 in regulated secretion of neuropeptides in mammalian neurons. We directly assessed DCV exocytosis at single-cell resolution in mouse hippocampal neurons and confirmed that Rab10 is a crucial regulator of DCV exocytosis also in mammalian systems, while not affecting synaptic vesicle (SV) exocytosis. However, instead of having a direct role in the DCV secretory pathway, we observed that Rab10 is involved in DCV exocytosis through ER-dependent processes, especially reduced ER Ca<sup>2+</sup> homeostasis and impaired global protein synthesis. Supplementation with leucine known to boost protein synthesis rescued the defects in DCV exocytosis. We therefore conclude that Rab10 plays a central role in regulating DCV exocytosis by maintaining Ca<sup>2+</sup> homeostasis and protein synthesis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Rab10 regulates neuronal outgrowth but is dispensable for synaptogenesis and SV exocytosis under intense stimulation</title><p>To study the role of Rab10 in regulated secretion, we utilized a knockdown strategy since complete knockout of Rab10 results in lethality at cell and organismal levels (<xref ref-type="bibr" rid="bib45">Lv et al., 2015</xref>). We selected two specific shRNA sequences, shRNA#9 and shRNA#11, to deplete Rab10 expression and a scrambled sequence as control. In mouse cortical neurons infected with either shRNA#9 or shRNA#11 at day in vitro 0 (DIV0), we observed a 75–95% decrease in Rab10 expression at DIV14 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Previous studies have shown that Rab10 regulates neuronal outgrowth (<xref ref-type="bibr" rid="bib75">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="bib77">Xu et al., 2014</xref>). Consistent with these findings, we observed a significantly reduced dendrite and axon length in neurons infected with shRNA#9 at DIV0 (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Rab10 is required for neuronal outgrowth but dispensable for synaptic vesicle (SV) exocytosis evoked by intense stimulations.</title><p>(<bold>A</bold>) Representative immunoblotting showing knockdown and rescue of Rab10 expression in cultured primary neurons infected with shRNA against Rab10 or rescue constructs (upper) and quantification of Rab10 levels (bottom). (<bold>B</bold>) Example images of control or Rab10 KD hippocampal neurons (days in vitro [DIV]14) stained for the dendrite marker MAP2 (blue), the synapse marker Syp1 (red), and the axonal marker SMI312 (green). Scale bar: 50 μm (upper) and 10 μm (bottom). (<bold>C</bold>) Quantification of the dendritic length (MAP2). (<bold>D</bold>) Quantification of the axonal length (SMI312). (<bold>E</bold>) Quantification of Syp1 intensity per synapse per neuron. (<bold>F</bold>) Quantification of the Syp1-positive synapse density in MAP2-positive dendrites. (<bold>G</bold>) Sholl analysis showing the mean number of dendritic branches against the distance from the soma. (<bold>H</bold>) Example neurons infected with the SV fusion marker SypHy (upper), typical kymographs of neurites showing SypHy intensity increase during stimulation and upon NH<sub>4</sub>Cl superfusion (bottom). (<bold>I</bold>) The average signal SypHy from active synapses, normalized from baseline to maximum fluorescence upon NH<sub>4</sub>Cl superfusion. (<bold>J</bold>) SV exocytosis determined as the ratio of the maximum SypHy intensity during stimulation to the maximum during NH<sub>4</sub>Cl stimulation. (<bold>K</bold>) SV endocytosis determined as the SypHy signal decay time constant τ in the 60 s after field stimulation. All data are plotted as mean ± s.e.m. (<bold>A</bold>) N=4, n=4, one-sample t-test. (<bold>C–G</bold>) Control: N=3, n=35; ShRNA#9: N=3, n=32. (<bold>J, K</bold>) Control: N=3, n=47; ShRNA#9: N=3, n=56. (<bold>C–F, J, K</bold>) A one-way ANOVA tested the significance of adding experimental group as a predictor. ****=p&lt;0.0001, **=p&lt;0.01, ns=not significant.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig1">Figure 1A</xref>, indicating the relevant bands and treatments.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94930-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94930-fig1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig1-v1.tif"/></fig><p>To test the effects of Rab10 depletion on synaptogenesis, SVs were quantified using the endogenous marker synaptophysin 1 (Syp1). Syp1 staining exhibited a punctate distribution at DIV14, indicating the accumulation of SVs in boutons/synapses, and no changes in the number of puncta per µm neurite or the intensity of Syp1 puncta (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref>). These data confirm that Rab10 regulates neurite outgrowth, but we found no evidence for a role in synaptogenesis.</p><p>To test whether Rab10 depletion affects SV exocytosis, hippocampal neurons were infected with the SV exocytosis reporter Synaptophysin-pHluorin (SypHy; <xref ref-type="fig" rid="fig1">Figure 1H</xref>; <xref ref-type="bibr" rid="bib29">Granseth et al., 2006</xref>). SV exocytosis was triggered by high-frequency electrical stimulation (HFS, 5 s 40 Hz). The total vesicle pool was measured by briefly superfusing Tyrode’s solution containing 50 mM NH<sub>4</sub>Cl. The fraction of fused SVs, determined by the ratio of SypHy intensity upon HFS to the maximum intensity upon NH<sub>4</sub>Cl superfusion, was comparable in the two groups (<xref ref-type="fig" rid="fig1">Figure 1I and J</xref>). In addition, SV endocytosis, measured by the fluorescence decay of SypHy after HFS, was unaffected by Rab10 depletion (<xref ref-type="fig" rid="fig1">Figure 1K</xref>). Therefore, we conclude that Rab10 is dispensable for SV exocytosis under intense stimulation.</p></sec><sec id="s2-2"><title>Rab10 is a major regulator of DCV exocytosis</title><p>To investigate the role of Rab10 in neuropeptide release, we depleted Rab10 levels at DIV0, expressed the DCV exocytosis reporter NPY-pHluorin at DIV9-10, and performed live-cell imaging at DIV14. Our previous studies have demonstrated that NPY-pHluorin almost exclusively localizes to DCVs as indicated by its strong co-localization with endogenous markers of DCVs, such as BDNF and the chromogranins CHGA and CHGB (<xref ref-type="bibr" rid="bib4">Arora et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Dominguez et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Persoon et al., 2019</xref>; <xref ref-type="bibr" rid="bib55">Persoon et al., 2018</xref>). To achieve single-vesicle resolution analysis of DCV exocytosis, we used single cultured hippocampal neurons on glial micro-islands. Neurons were stimulated by 16 trains of 50 action potentials (APs) at 50 Hz, a protocol known to trigger robust DCV exocytosis (<xref ref-type="bibr" rid="bib7">Balkowiec and Katz, 2002</xref>; <xref ref-type="bibr" rid="bib21">Emperador-Melero et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Gärtner and Staiger, 2002</xref>; <xref ref-type="bibr" rid="bib31">Hartmann et al., 2001</xref>; <xref ref-type="bibr" rid="bib49">Moro et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Persoon et al., 2019</xref>). Fusion events were detected as a rapid appearance of fluorescent puncta (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>). DCV exocytosis in Rab10 KD neurons was significantly reduced by 60% compared to control neurons (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>). Furthermore, the total number of DCVs was reduced by 30% in Rab10 KD neurons (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). The fusion fraction, which represents the number of DCV fusion events relative to the remaining DCV pool after stimulation, was also significantly decreased by 50% in Rab10 KD neurons (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>). Overexpression of wild-type (WT), knockdown-resistant Rab10 rescued DCV exocytosis deficits in Rab10 KD neurons (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C–F</xref>).</p><p>To overcome the potential confounding effects of impaired neurite outgrowth (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and reduced total DCV pool (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) upon Rab10 depletion starting at DIV0, we adopted a more acute approach to interfere with Rab10 function, and late enough not to affect neuronal morphology and the total DCV pool. Neurons were transfected with shRNA against Rab10 at DIV7, fixed at DIV14, and stained with markers for dendrites (MAP2), axons (SMI312), and SVs (Syp1). Rab10 expression was reduced by 70% after 7 days of infection (<xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). No significant alterations in total dendrite length, axon length (<xref ref-type="fig" rid="fig2">Figure 2A–C and E</xref>), or synapse density (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) were observed in Rab10 KD neurons under these conditions. Therefore, to eliminate confounding effects on morphological parameters, we reevaluated DCV exocytosis and all further experiments in neurons infected with shRNA at DIV7. DCV exocytosis in Rab10 KD neurons remained significantly lower by 50% compared to control neurons (<xref ref-type="fig" rid="fig2">Figure 2F–I</xref>). The fusion fraction was also significantly reduced by 65% in Rab10 KD neurons (<xref ref-type="fig" rid="fig2">Figure 2K</xref>). Overexpression of WT Rab10 rescued DCV exocytosis deficits. No significant differences in the total number of DCVs (<xref ref-type="fig" rid="fig2">Figure 2J</xref>), DCV transport (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A, B, and E</xref>), or cargo loading (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2F–K</xref>) were observed. Moreover, only 10% of DCVs co-transport with Rab10 (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). Thus, these data indicate that Rab10 depletion specifically inhibits activity-dependent neuropeptide release in hippocampal neurons, without effects on DCV biogenesis, cargo loading, and transport and independent of Rab10’s established role in neuronal outgrowth.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Rab10 is a major regulator of dense core vesicle (DCV) exocytosis.</title><p>(<bold>A</bold>) Example images of control and Rab10 KD hippocampal neurons (days in vitro [DIV]14) stained for MAP2 (blue), Syp1 (red), and SMI312 (green). Scale bar: 30 μm. (<bold>B</bold>) Quantification of the dendritic length (MAP2). (<bold>C</bold>) Quantification of the axonal length (SMI312). (<bold>D</bold>) Quantification of the Syp1-positive synapse density in MAP2-positive dendrites. (<bold>E</bold>) Sholl analysis showing the mean number of dendritic branches against the distance from the soma. (<bold>F</bold>) Schematic representation of DCV fusion assay. DCVs are labeled with NPY-pHluorin, and neurons are stimulated with one train of 16 bursts of 50 action potentials (APs) at 50 Hz (light blue bars). (<bold>G</bold>) Representative neurons during electrical stimulation superimposed with NPY-pHluorin fusion events (green dots). Scale bar: 5 μm. (<bold>H</bold>) Cumulative plot of DCV fusion events per cell. Light blue bars represent the stimulation trains. (<bold>I</bold>) Summary graph of DCV fusion events per cell. (<bold>J</bold>) The total number of DCVs (total pool) of neurons analyzed in H, measured as the number of NPY-pHluorin puncta upon NH<sub>4</sub>Cl perfusion. (<bold>K</bold>) Fraction of NPY-pHluorin-labeled DCV fusing during stimulation. All data are plotted as mean ± s.e.m. (<bold>B–D</bold>) Control: N=3, n=31; ShRNA#9: N=3, N=28; ShRNA#11: N=3, n=31. (<bold>I–K</bold>) Control: N=4, n=36; shRNA#9: N=4, N=37; shRNA#11: N=4, n=30; Rescue: N=4, n=34. A one-way ANOVA tested the significance of adding experimental group as a predictor. ****=p&lt;0.0001, ***=p&lt;0.001, **=p&lt;0.01, *=p&lt;0.05, ns=not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Rab10 depletion at day in vitro (DIV)0 impedes dense core vesicle (DCV) fusion.</title><p>(<bold>A</bold>) Schematic representation of DCV fusion assay. DCVs are labeled with NPY-pHluorin, and neurons are stimulated with one train of 16 bursts of 50 action potentials (APs) at 50 Hz (light blue bars). (<bold>B</bold>) Representative neurons during electrode stimulation superimposed with NPY-pHluorin fusion events (green dots). Scale bar: 10μm. (<bold>C</bold>) Cumulative plot of DCV fusion events per cell. (<bold>D</bold>) Summary graph of DCV fusion events per cell. (<bold>E</bold>) Total number of DCVs (total pool) of neurons, measured as the number of NPY-pHluorin puncta upon NH<sub>4</sub>Cl perfusion. (<bold>F</bold>) Fraction of NPY-pHluorin-labeled DCV fusing during stimulation. All data are plotted as mean ± s.e.m. (<bold>D–F</bold>) Control: N=3, n=26; Rab10 KD: N=3, n=47; Rescue: N=3, n=22. (<bold>D–F</bold>) A one-way ANOVA tested the significance of adding experimental group as a predictor. ***=p&lt;0.001, **=p&lt;0.01, *=p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Rab10 depletion does not affect dense core vesicle (DCV) transport or cargo loading.</title><p>(<bold>A</bold>) Representative kymographs illustrating the transport of NPY-mCherry-labeled DCVs in control and Rab10 KD neurons. (<bold>B</bold>) Quantification of average velocity (µm/s) of control and Rab10 KD neurons. (<bold>C</bold>) Quantification of average distance moved from the start (µm) of control and Rab10 KD neurons. (<bold>D</bold>) Histogram of average velocity (µm/s) of control and Rab10 KD neurons. (<bold>E</bold>) Histogram of average distance moved from the start (µm) of control and Rab10 KD neurons. (<bold>F</bold>) Typical neurite expressing NPY-pHluorin during baseline (b) and during stimulation (s). Scale bar: 10μm. (<bold>G</bold>) Average traces of NPY-pHluorin fusion events aligned at the moment of fusion (0 s). (<bold>H</bold>) Quantification of NPY-pHluorin baseline fluorescence before stimulation. (<bold>I</bold>) Quantification of average NPY-pHluorin fusion intensity per cell. All data are plotted as mean ± s.e.m. (<bold>B, C</bold>) Control: N=3, n=18; Rab10 KD: N=3, n=17. (<bold>H, I</bold>) Control: N=3, n=37; Rab10 KD: N=3, n=35. A one-way ANOVA tested the significance of adding experimental group as a predictor. ns=not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Rab10 does not typically co-transport together with dense core vesicles (DCVs).</title><p>(<bold>A</bold>) Representative kymographs of neurons co-infected with Rab10-GFP and NPY-mCherry. (<bold>B</bold>) Percentage moving DCVs that co-transport with Rab10. Data are plotted as mean ± s.e.m. (N=3, n=22). Data are plotted as mean ± s.e.m.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig2-figsupp3-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Proteins involved in synaptic transmission and translation are severely dysregulated upon Rab10 depletion</title><p>To comprehensively investigate Rab10 function in mature neurons, mass spectrometry proteomics was performed on Rab10 KD and control neurons at DIV14. A total of approximately 5400 unique proteins were identified and quantified in two biological replicates. The complete list of proteins quantified in this study is presented in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>. Only differentially expressed proteins detected with high confidence characterized by a log2(fold change)&gt;0.56 and q-value&lt;0.01 were included in the subsequent analysis. Among the dysregulated proteins, 71% were upregulated, while 29% were downregulated, resulting in a significant dysregulation of 19% of the total protein pool in Rab10 KD neurons. These data indicate that Rab10 depletion leads to major neuronal proteome dysregulation within 7 days after initiating knockdown (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Depletion of Rab10 leads to dysregulation of proteins enriched in presynaptic transmission and cytosolic translation.</title><p>(<bold>A</bold>) Volcano plots showing significantly dysregulated proteins in Rab10-depleted neurons. (<bold>B</bold>) Gene Ontology (GO) enrichment analysis of functional pathways of the significant hits with ClueGO. Shown are the Bonferroni corrected p-values. (<bold>C</bold>) GO enrichment analysis of subcellular localization of the significant hits with ClueGO. Shown are the Bonferroni corrected p-values. (<bold>D</bold>) Sunburst plot showing the annotation in synaptic function of the altered proteins in Rab10-depleted neurons. (<bold>E</bold>) Sunburst plot showing the annotation in synaptic location of the altered proteins in Rab10-depleted neurons. (<bold>F</bold>) Log2 fold changes of synaptic proteins within SynGO terms. Downregulated proteins are shown in blue and upregulated proteins are shown in black. (<bold>G</bold>) Examples of proteins that are significantly affected by Rab10 depletion grouped by their subcellular localization. Heat maps represent the degree of up- or downregulation. (<bold>H</bold>) Selective MS data analysis of ER-related proteins in Rab10 KD neurons. Bars show the fold change of the indicated peptides compared to the control.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Proteome analysis of neuronal cultures by mass spectrometry – complete list of proteins.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-94930-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig3-v1.tif"/></fig><p>To gain insights into the functional consequences of Rab10 depletion, we performed Gene Ontology (GO) analysis using ClueGO (<xref ref-type="bibr" rid="bib10">Bindea et al., 2009</xref>). This analysis revealed that biological processes related to chemical synaptic transmission were notably affected by Rab10 depletion (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). In addition, several biological processes related to protein synthesis, such as cytoplasmic translation and ribosomal large subunit biogenesis, were among the top 5 terms with the lowest p-values (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Subcellular localization analysis of these dysregulated proteins upon Rab10 depletion showed that cytosolic ribosomal proteins were the most significantly affected, followed by dendritic proteins (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Further characterization of the dysregulated synaptic proteins was performed using SynGO (<xref ref-type="bibr" rid="bib39">Koopmans et al., 2019</xref>). Among the 391 significantly dysregulated proteins annotated in SynGO, 205 were classified as presynaptic proteins and 237 as postsynaptic proteins. GO enrichment analysis revealed that biological processes in metabolism were most dysregulated upon Rab10 depletion. Among them, both pre- and postsynaptic translation were significantly dysregulated (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Consistent with the ClueGO analysis, SynGO highlighted a significant dysregulation of presynaptic (34 of 391) and postsynaptic ribosomal proteins (44 of 391), supporting the involvement of Rab10 in the regulation of neuronal protein synthesis (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Interestingly, all dysregulated ribosomal proteins were upregulated upon Rab10 depletion, which contrasts with the mostly downregulated expression observed in the other classes of proteins (such as synaptic and cytoskeletal proteins) (<xref ref-type="fig" rid="fig3">Figure 3F–G</xref>). Taken together, GO analysis with both ClueGO and SynGO indicates a dysfunction of protein translation in Rab10 KD neurons.</p><p>Loss of Rab10 expression has been associated with altered ER morphology in mouse embryonic cells (<xref ref-type="bibr" rid="bib45">Lv et al., 2015</xref>), which may explain the selective upregulation of proteins involved in ribosome function in our proteomics data. Indeed, ER proteins were dysregulated substantially upon Rab10 depletion. Specifically, several rough ER (RER) proteins showed differential regulation, with SEC61A1 being upregulated, SEC61G being downregulated, and CLIMP remaining unchanged (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). Most tubular ER proteins, such as RTN3/4 and VAPB, were robustly decreased. Interestingly, one of the ER membrane Ca<sup>2+</sup> channels, SERCA2, showed a 50% reduction upon Rab10 depletion (<xref ref-type="fig" rid="fig3">Figure 3H</xref>).</p><p>Taken together, these analyses reveal that Rab10 depletion leads to major changes in protein expression, especially synaptic and ribosomal proteins, the latter all upregulated in Rab10-depleted neurons which suggests that protein synthesis is dysregulated, potentially due to altered ER function.</p></sec><sec id="s2-4"><title>Rab10 regulates ER morphology and ribosomal protein levels</title><p>Given the substantial dysregulation of synapse and ribosome/ER proteins, we investigated synapses and ER further using electron microscopy (<xref ref-type="fig" rid="fig4">Figure 4</xref>). These analyses revealed an apparently normal synapse morphology in Rab10-depleted neurons with many SVs clustered at the active zone, while DCVs were sparsely distributed along neurites and near the active zone (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The length of the active zone and postsynaptic density were both decreased by 10% upon Rab10 depletion (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). However, other parameters of synaptic ultrastructure, such as the diameter of SVs or DCVs, and the number of SVs per synapse, remain unchanged in Rab10 KD neurons (<xref ref-type="fig" rid="fig4">Figure 4E–H</xref>). Hence, despite substantial dysregulation of synaptic proteins, overall synapse morphology was hardly affected.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Rab10 regulates synapse size and endoplasmic reticulum (ER) morphology.</title><p>(<bold>A</bold>) Representative electron microscopy (EM) pictures showing the ultrastructure of synapses. Scale bar: 100 nm. Synaptic ER is indicated by red dotted lines. (<bold>B</bold>) Representative EM pictures showing the ultrastructure of soma. Rough ER (rER) is indicated by red dotted lines. M: mitochondrion, G: Golgi. Scale bar: 100 nm. (C) Quantification of the length of active zone and postsynaptic density (PSD). (D) Quantification of the length of PSD. (E) Quantification of synaptic vesicle (SV) number per synapse and SV diameter. (F) Quantification of SV diameter. (G) Quantification of dense core vesicle (DCV) diameter. (H) Frequency distribution of DCVs by diameter. (I) Quantification of the diameter of rER. Data are plotted with superplot (C–G, I), where averages from three independent cultures are shown as large circles and single observations are shown as dots. Horizontal lines represent the means of the averages from 3 weeks. Data from different cultures are grouped with different colors. (<bold>C–D</bold>) Control: N=3, n=184; shRNA#9: N=3, n=187. (<bold>E</bold>) Control: N=3, n=189; shRNA#9: N=3, n=188. (<bold>F</bold>) Control: N=3, n=1770; shRNA#9: N=3, n=1803. (<bold>G</bold>) Control: N=3, n=137; shRNA#9: N=3, n=122. (<bold>I</bold>) Control: N=3, n=63; shRNA#9: N=3, n=64. (<bold>C–G, I</bold>) Linear mixed model analysis. ***=p&lt;0.001, *=p&lt;0.05, ns=not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Altered endoplasmic reticulum (ER) morphology in Rab10 KD neurons.</title><p>(<bold>A</bold>) Example images of control or Rab10 KD hippocampal neurons (days in vitro [DIV]14) stained for the dendrite marker MAP2 (green), two ER markers KDEL (red) and RTN4 (magenta). Scale bar: 50 μm. (<bold>B</bold>) Quantification of RTN4 intensity in MAP2-positive dendrites. (<bold>C</bold>) Quantification of KDEL intensity in MAP2-positive dendrites. (<bold>D</bold>) The ratio of neuritic to somatic RTN4 intensity (N/S). (<bold>E</bold>) The ratio of neuritic to somatic KDEL intensity (N/S). All data are plotted as mean ± s.e.m. (<bold>B–D</bold>) Control: N=3, n=18; Rab10 KD: N=3, n=18. (<bold>B–D</bold>) A one-way ANOVA tested the significance of adding experimental group as a predictor. ****=p&lt;0.0001, ***=p&lt;0.001, **=p&lt;0.01, *=p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Impaired endoplasmic reticulum (ER) dynamics in Rab10 KD neurons.</title><p>(<bold>A</bold>) Representative time-lapse of ER-mCherry3 signal before (upper), upon (middle), and after (bottom) photobleaching. Scale bar: 20 μm. (<bold>B</bold>) Average normalized ER-mCherry3 fluorescence recovery after photobleaching in control and Rab10 KD hippocampal neurons. (<bold>C</bold>) Normalized ER-mCherry3 fluorescence recovery after photobleaching at T=220 s in control and Rab10 KD hippocampal neurons. All data are plotted as mean ± s.e.m. (<bold>B, C</bold>) Control: N=3, n=23; Rab10 KD: N=3, n=23. (<bold>B, C</bold>) A one-way ANOVA tested the significance of adding experimental group as a predictor. ****=p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Rab10 depletion does not increase endoplasmic reticulum (ER) stress.</title><p>(<bold>A</bold>) Representative images of wild-type (WT) neurons treated with vehicle (top) or tunicamycin (TM, middle) and Rab10 KD neurons treated with vehicle (bottom). Neurons were stained for ATF4 and MAP2. Scale bar: 50μm. (<bold>B</bold>) Quantification of ATF4 intensity in soma from each condition. All data are presented as mean ± s.e.m. WT+vehicle: N=2, n=25; WT+vehicle: N=2, n=30; Rab10 KD+vehicle: N=2, n=14. A one-way ANOVA tested the significance of adding experimental group as a predictor. ****=p&lt;0.0001, ns=not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig4-figsupp3-v1.tif"/></fig></fig-group><p>Tubular ER was also observed in some presynaptic sections, consistent with previous studies (<xref ref-type="bibr" rid="bib17">Deng et al., 2021</xref>; <xref ref-type="bibr" rid="bib19">Droz et al., 1975</xref>; <xref ref-type="bibr" rid="bib76">Wu et al., 2017</xref>). The percentage of synaptic sections containing tubular ER was decreased by 24% (37% in control versus 28% in Rab10 KD). rER was also studied in the somata of Rab10-depleted and control neurons (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). The diameter of rER tubes was reduced by 15% in Rab10 KD neurons. Hence, the substantial dysregulation of ribosomal and ER proteins in Rab10-depleted neurons was accompanied by changes in the abundance of synaptic ER and small changes in ER morphology in the soma.</p><p>To study these effects on ER abundance and morphology further, we performed immunofluorescence staining for two endogenous ER markers, KDEL and RTN4. The average fluorescence intensity of RTN4 and KDEL staining was significantly decreased by 35% and 25% respectively in Rab10 KD neurons (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–C</xref>). The relative distributions of RTN4 and KDEL in neurites, as calculated by the intensity ratio of these two proteins in neurites over their somatic intensity, were reduced by 25% and 13%, respectively (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D and E</xref>). In conclusion, the ultrastructural changes in ER abundance and morphology upon Rab10 depletion were accompanied by altered distribution of axonal ER, without affecting the ultrastructure of SVs and DCVs.</p><p>Finally, given the dynamic nature of ER tubular networks and the involvement of Rab10 in ER tubule extension in COS-7 cells (<xref ref-type="bibr" rid="bib23">English and Voeltz, 2013</xref>), we tested ER dynamics in Rab10 KD and control neurons expressing the luminal ER marker mCherry-ER3 using live-cell imaging at DIV8, and performed FRAP experiments at DIV14. The recovery of mCherry-ER3 intensity after photobleaching was significantly slower in Rab10 KD neurons with only 50% recovery within 3 min, compared to 80% recovery in control neurons (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>). Collectively, these data indicate that Rab10 depletion leads to reduced levels of ER-resident proteins altered ER abundance and morphology, and impaired ER dynamics.</p></sec><sec id="s2-5"><title>Rab10 regulates SERCA2 levels and ER Ca<sup>2+</sup> homeostasis</title><p>The ER is the largest internal Ca<sup>2+</sup> source in neurons and plays a crucial role in maintaining neuronal Ca<sup>2+</sup> homeostasis (<xref ref-type="bibr" rid="bib36">Karagas and Venkatachalam, 2019</xref>). The maintenance of ER Ca<sup>2+</sup> primarily relies on the Sarco Endoplasmic Reticulum Calcium ATPase (SERCA), a Ca<sup>2+</sup> pump. Among the three major paralogs of SERCA, SERCA2 is particularly enriched in neurons (<xref ref-type="bibr" rid="bib11">Britzolaki et al., 2018</xref>; <xref ref-type="bibr" rid="bib54">Periasamy and Kalyanasundaram, 2007</xref>; <xref ref-type="bibr" rid="bib78">Xu and Van Remmen, 2021</xref>). Consistent with the proteomic analysis which revealed a reduced SERCA2 expression upon Rab10 depletion (<xref ref-type="fig" rid="fig3">Figure 3</xref>), immunoblotting confirmed the reduction of SERCA2 levels, showing a 50% reduction in Rab10 KD neurons (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). Therefore, ER alternations in Rab10 KD neurons may disrupt Ca<sup>2+</sup> homeostasis, which is essential for DCV exocytosis.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Reduced SERCA2 levels and impaired endoplasmic reticulum (ER) Ca<sup>2+</sup> homeostasis in Rab10 KD neurons.</title><p>(<bold>A</bold>) Typical immunoblot showing reduced SERCA2 levels in Rab10 KD hippocampal neurons. (<bold>B</bold>) Quantification of protein levels in Rab10 KD neurons normalized to control. (<bold>C</bold>) Quantification of somatic ER Ca<sup>2+</sup> concentration. (<bold>D</bold>) Quantification of dendritic ER Ca<sup>2+</sup> concentration. (<bold>E</bold>) Representative image of a neuron infected with ER-GCaMP6-150 displayed with a pseudo line. Scale bar: 3 μm. (<bold>F</bold>) Typical kymographs of the somatic intensity of ER-GCaMP6-150 showing the intensity decrease upon caffeine superfusion (red line) and the recovery in intensity after caffeine washout. Scale bar: 10 s. (<bold>G</bold>) Average normalized ER-GCaMP6-150 fluorescence recovery after caffeine treatment. (<bold>H</bold>) Normalized ER-GCaMP6-150 fluorescence recovery after caffeine treatment at T=190 s. All data are plotted as mean ± s.e.m. (B) Control: N=4, n=4; Rab10 KD: N=4, n=4; (C-D) Control: N=3, n=17; Rab10 KD: N=3; n=17; Rescue: N=3, n=17; (H) Control: N=3, n=23; Rab10 KD: N=3; n=24; GDP-Rab10: n=3, n=10; Rescue: N=3, n=24. A one-way ANOVA tested the significance of adding experimental group as a predictor. ****=p&lt;0.0001, ***=p&lt;0.001, **=p&lt;0.01, ns=not significant.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig5">Figure 5A</xref>, indicating the relevant bands and treatments.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94930-fig5-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94930-fig5-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Caffeine triggers less endoplasmic reticulum (ER) Ca<sup>2+</sup> release in Rab10 KD neurons.</title><p>(<bold>A</bold>) Left: representative cytosolic Fluo-5 AM signals upon caffeine perfusion. Right: representative kymographs of cytosolic Fluo-5 AM signals upon caffeine perfusion in somas. (<bold>B</bold>) Average traces of Fluo-5 AM signals. (<bold>C</bold>) Quantification of the peak values of the Fluo-5 AM fluorescence traces upon caffeine perfusion. (<bold>D</bold>) Quantification of the area under the curve (AUC) of the Fluo-5 AM fluorescence traces upon caffeine perfusion. All data are plotted as mean ± s.e.m. (<bold>C, D</bold>) Control: N=3, n=44; Rab10 KD: N=3, n=35. (<bold>C, D</bold>) A one-way ANOVA tested the significance of adding experimental group as a predictor. ****=p&lt;0.0001, **=p&lt;0.01.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig5-figsupp1-v1.tif"/></fig></fig-group><p>To test this, we next measured the Ca<sup>2+</sup> concentration in ER ([Ca<sup>2+</sup>]<sub>ER</sub>) using the ER Ca<sup>2+</sup> indicator ER-GCaMP6 (<xref ref-type="bibr" rid="bib16">de Juan-Sanz et al., 2017</xref>). We observed a reduction in [Ca<sup>2+</sup>]<sub>ER</sub> in soma from 130 μM in control neurons to about 70 μM in Rab10-depleted neurons (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). [Ca<sup>2+</sup>]<sub>ER</sub> in neuritis was also reduced by 15% in Rab10 KD neurons (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). The reduction of [Ca<sup>2+</sup>]<sub>ER</sub> was rescued by the expression of a knockdown-resistant Rab10 construct. To validate this observation, we assessed ER Ca<sup>2+</sup> homeostasis indirectly by measuring the effect of caffeine on cytosolic Ca<sup>2+</sup> concentration. As expected, in the absence of extracellular Ca<sup>2+</sup>, caffeine application (1 μM) triggered an increase in cytosolic Ca<sup>2+</sup> due to Ca<sup>2+</sup> release from the ER in both WT and Rab10-depleted neurons. However, the peak and the area of the caffeine-induced Ca<sup>2+</sup> response curves were both reduced by 30% in Rab10 KD neurons (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p><p>Furthermore, we examined ER Ca<sup>2+</sup> dynamics following a 10 min caffeine treatment. Caffeine activates the ryanodine receptor (RyR), leading to the depletion of ER Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib22">Endo, 1975</xref>; <xref ref-type="bibr" rid="bib26">Fujimoto et al., 1980</xref>). As expected, perfusion with caffeine induced ER Ca<sup>2+</sup> depletion, followed by recovery toward pre-stimulation levels (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>). In WT neurons, Ca<sup>2+</sup> levels were recovered by 90% at T=190 s. However, the refilling of ER Ca<sup>2+</sup> was significantly delayed in Rab10 KD neurons or GDP-Rab10 expressing neurons. Ca<sup>2+</sup> levels were only recovered by 50% at T=190 s (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>) in these neurons.</p><p>Finally, to investigate the consequence of the ER Ca<sup>2+</sup> depletion on neuronal Ca<sup>2+</sup> homeostasis in Rab10 KD neurons, we measured cytosolic Ca<sup>2+</sup> responses triggered by APs using the Ca<sup>2+</sup> indicator Fluo5F (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>) and the genetically encoded Synaptophysin-GCaMP6 (<xref ref-type="fig" rid="fig6">Figure 6D–F</xref>). The AP-induced Ca<sup>2+</sup> responses in the soma, as measured by Fluo5F, were reduced by 40% upon Rab10 depletion (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Similarly, the AP-induced Ca<sup>2+</sup> responses in presynaptic nerve terminals, measured by Synaptophysin-GCaMP6, were also reduced (20%, <xref ref-type="fig" rid="fig6">Figure 6F</xref>), although this effect was smaller than the effects of Rab10 KD on ER Ca<sup>2+</sup> levels and caffeine-induced ER Ca<sup>2+</sup> depletion (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Taken together, these data suggest that Rab10 knockdown leads to ER Ca<sup>2+</sup> depletion and impairs neuronal Ca<sup>2+</sup> homeostasis, which may be attributed to the reduced levels of SERCA2 level and slower ER Ca<sup>2+</sup> refilling and may contribute to the impaired DCV exocytosis.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Impaired neuronal Ca<sup>2+</sup> influx triggered by electrical stimulation.</title><p>(<bold>A</bold>) Representative time-lapse of cytosolic Fluo-5 AM upon electrical stimulation (16 action potentials [APs], 50 Hz) in somas of hippocampal neurons. Scale bar: 10 μm. (<bold>B</bold>) Average normalized response of somatic Fluo-5 AM fluorescence upon stimulation (16 APs, 50 Hz) in hippocampal neurons. (<bold>C</bold>) Quantification of the area under the curve (AUC) of the Fluo-5 AM fluorescence traces. (<bold>D</bold>) Typical neurons infected with Synaptophysin-GCaMP6 (upper), typical kymograph of a neurite (bottom) showing Synaptophysin-GCaMP6 intensity increase upon electrical stimulation (16 APs, 50 Hz, blue bars). Scale bar: 5 μm. (<bold>E</bold>) Average normalized response of Synaptophysin-GCaMP6 fluorescence intensity at presynaptic boutons upon stimulation (16 APs, 50 Hz) in hippocampal neurons. (<bold>F</bold>) Quantification of the AUC of the Synaptophysin-GCaMP6 fluorescence traces in control and Rab10 KD neurons. All data are plotted as mean ± s.e.m. (<bold>C</bold>) Control: N=4, n=24; Rab10 KD: N=4, n=30; Rescue: N=4, n=27. (<bold>F</bold>) Control: N=3, n=33; Rab10 KD: N=3; n=27. A one-way ANOVA tested the significance of adding experimental group as a predictor. **=p&lt;0.01, *=p&lt;0.05, ns=not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig6-v1.tif"/></fig></sec><sec id="s2-6"><title>Rab10 depletion impairs ionomycin-induced DCV exocytosis</title><p>To determine whether the impaired Ca<sup>2+</sup> signaling explains the DCV exocytosis deficiency in Rab10 KD neurons, we stimulated DCV exocytosis using the Ca<sup>2+</sup> ionophore ionomycin. This approach bypasses cellular Ca<sup>2+</sup> homeostasis and artificially increases the intracellular Ca<sup>2+</sup> concentration enough to trigger DCV exocytosis (<xref ref-type="bibr" rid="bib56">Persoon et al., 2019</xref>). Unexpectedly, DCV exocytosis was still reduced in Rab10 KD neurons (<xref ref-type="fig" rid="fig7">Figure 7A and B</xref>). Although the reduction was substantial, 45%, this impairment was not as substantial as observed for AP-induced DCV exocytosis (65%, <xref ref-type="fig" rid="fig2">Figure 2K</xref>). The total number of DCV was nearly identical between control and Rab10 KD neurons (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Thus, although a minor fraction of the DCV exocytosis deficits may be explained by impaired Ca<sup>2+</sup> signaling (difference between 45% and 65%), other deficits explain most of the DCV exocytosis deficiency in Rab10 KD neurons.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Impaired dense core vesicle (DCV) fusion induced by ionomycin in Rab10 KD neurons.</title><p>(<bold>A</bold>) Representative neurons during electrical stimulation superimposed with NPY- pHluorin fusion events (green dots). Scale bar: 10 μm. (<bold>B</bold>) Cumulative plot of DCV fusion events per cell. (<bold>C</bold>) Fraction of NPY-pHluorin-labeled DCVs fusing during stimulation. (<bold>D</bold>) The total number of DCVs (total pool) of neurons analyzed in B, measured as the number of NPY-pHluorin puncta upon NH<sub>4</sub>Cl perfusion. All data are plotted as mean ± s.e.m. (C, D) Control: N=3, n=20; Rab10 KD: N=3, n=21. (C, D) A one-way ANOVA tested the significance of adding experimental group as a predictor. *=p&lt;0.05, ns=not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig7-v1.tif"/></fig></sec><sec id="s2-7"><title>Rab10 regulates neuronal protein synthesis</title><p>Since significant dysregulation of ER markers and ribosomal proteins was observed upon Rab10 depletion, we investigated the effects of Rab10 on protein synthesis using SUnSET to detect nascent peptides formed during puromycin pulse labeling (<xref ref-type="bibr" rid="bib62">Schmidt et al., 2009</xref>). SUnSET analysis revealed that global protein synthesis was reduced by 30% upon Rab10 depletion (<xref ref-type="fig" rid="fig8">Figure 8A and B</xref>).</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Leucine supplementation ameliorates the deficits in protein synthesis and neuropeptide release in Rab10 KD neurons.</title><p>(<bold>A</bold>) Representative western blot showing puromycinilated proteins as a measure for de novo protein synthesis in each condition. (<bold>B</bold>) Quantification of puromycin intensity in each condition. (<bold>B</bold>) Representation of the dense core vesicle (DCV) fusion assay. Leucine (5 μM) was added to the culture media and incubated for 72 hr before DCV fusion assay. DMSO (1‰) was used as a control. (<bold>C</bold>) Cumulative plot of DCV fusion events per cell. (<bold>D</bold>) Fraction of NPY-pHluorin-labeled DCVs fusing during stimulation. (<bold>E</bold>) The total number of DCVs (total pool) of neurons analyzed in D, E, measured as the number of NPY-pHluorin puncta upon NH<sub>4</sub>Cl perfusion. All data are plotted as mean ± s.e.m. (<bold>B</bold>) All: N=3, n=3; (<bold>E, F</bold>) Control: N=3, n=47; Control+leu: N=3, n=45; Rab10 KD: N=3; n=61; Rab10+leu: N=3, n=54. Rab10 KD+Rab10: N=3, n=24. (<bold>B</bold>) One-sample t-test. (<bold>E, F</bold>) A one-way ANOVA tested the significance of adding experimental group as a predictor. **=p&lt;0.01, *=p&lt;0.05, ns=not significant.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig8">Figure 8A</xref>, indicating the relevant bands and treatments.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94930-fig8-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig8">Figure 8A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94930-fig8-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Rab10 depletion does not upregulate mTORC1 pathway.</title><p>(<bold>A</bold>) Typical immunoblot showing pS6K1 levels in each condition. (<bold>B</bold>) Quantification of relative pS6K1 levels in each condition. All data are plotted as mean ± s.e.m. (<bold>C</bold>) Control, Control+Leu: N=2, n=2, Rab10 KD, Rab10 KD+Leu: N=2, n=4.</p><p><supplementary-material id="fig8s1sdata1"><label>Figure 8—figure supplement 1—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>, indicating the relevant bands and treatments.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94930-fig8-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata2"><label>Figure 8—figure supplement 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-94930-fig8-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig8-figsupp1-v1.tif"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 2.</label><caption><title>Leucine supplementation does not rescue endoplasmic reticulum (ER) morphological deficiency in Rab10 KD neurons.</title><p>(<bold>A</bold>) Typical examples showing the KDEL signals in each condition. Scale bar: 50 μm. (<bold>B</bold>) Quantification of RTN4 intensity in MAP2-positive dendrites. (<bold>C</bold>) The ratio of neuritic to somatic RTN4 intensity (N/S). All data are plotted as mean ± s.e.m. (<bold>B, C</bold>) Control: N=3, n=10; Rab10 KD: N=3, n=11; Rab10 KD+Leu: N=3; n=11. A one-way ANOVA tested the significance of adding experimental group as a predictor. ****=p&lt;0.0001, ns=not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig8-figsupp2-v1.tif"/></fig><fig id="fig8s3" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 3.</label><caption><title>Overexpression of SERCA2 does not rescue the dense core vesicle (DCV) fusion deficits in Rab10 KD neurons.</title><p>(<bold>A</bold>) Typical examples showing the SERCA2 signals in each condition. Scale bar: 50 μm. (<bold>B</bold>) Cumulative plot of DCV fusion events per cell. (<bold>C</bold>) Summary graph of DCV fusion events per cell. (<bold>D</bold>) Total number of DCVs (total pool) of neurons, measured as the number of NPY-pHluorin puncta upon NH4Cl perfusion. (<bold>E</bold>) Fraction of NPY-pHluorin-labeled DCV fusing during stimulation. All data are plotted as mean ± s.e.m. (<bold>C–E</bold>) Control: N=2, n=10; Rab10 KD: N=2, n=13; SERCA2 OE: N=2; n=15. A one-way ANOVA tested the significance of adding experimental group as a predictor. ***=p&lt;0.001, **=p&lt;0.01, ns=not significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-fig8-figsupp3-v1.tif"/></fig></fig-group><p>Protein synthesis impairments may be rescued by supplementation with leucine, a branched-chain amino acid, that promotes protein synthesis by activating the mTOR pathway (<xref ref-type="bibr" rid="bib3">Ananieva et al., 2016</xref>). To test this in Rab10 KD neurons, additional L-leucine was added to the culture medium to increase the concentration to 5 mM for 3 days. Indeed, 5 mM leucine supplementation significantly restored global protein synthesis deficits caused by Rab10 depletion (<xref ref-type="fig" rid="fig8">Figure 8A and B</xref>).</p><p>Finally, a similar impairment in global protein synthesis was observed when a loss-of-function mutant of Rab10 (Rab10T23N) was overexpressed in WT neurons (<xref ref-type="fig" rid="fig8">Figure 8A and B</xref>). The deficit in protein translation is unlikely attributable to the upregulated mTORC1 signaling as the relative phosphorylation level of pS6K1 was unaffected in Rab10 KD neurons (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). Thus, Rab10 depletion or Rab10T23N expression reduces global protein synthesis in neurons, probably by dysregulation of ER and ribosomal function.</p></sec><sec id="s2-8"><title>Leucine supplementation restores normal DCV exocytosis</title><p>We hypothesized that protein synthesis deficits in Rab10-depleted neurons explain most of the impaired DCV exocytosis (in addition to a minor fraction explained by disturbed Ca<sup>2+</sup> homeostasis, see above) and tested whether leucine supplementation could rescue the DCV exocytosis deficits in Rab10 KD neurons. Rab10-depleted neurons expressing NPY-pHluorin were treated with 5 mM leucine 3 days before live-cell imaging or with dimethyl sulfoxide (DMSO) as a control. Leucine supplementation restored DCV exocytosis by 80% caused by Rab10 depletion but did not alter DCV exocytosis in control neurons (<xref ref-type="fig" rid="fig8">Figure 8C–F</xref>). However, leucine supplementation failed to rescue the defects in ER morphology in Rab10 KD neurons (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>).</p><p>These results suggest that impaired protein synthesis is a major factor contributing to DCV exocytosis deficits in Rab10-depleted neurons.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we investigated the function of Rab10 in neuropeptide release in mature mouse hippocampal neurons. We found that DCV exocytosis triggered by AP trains was reduced by 65% upon Rab10 depletion, whereas SV exocytosis was unaffected. In addition, we observed a depleted ER Ca<sup>2+</sup> pool and an impaired AP-induced Ca<sup>2+</sup> response in Rab10 KD neurons. However, DCV exocytosis triggered by Ca<sup>2+</sup> ionophore ionomycin, a triggering method independent of Ca<sup>2+</sup> channels and internal Ca<sup>2+</sup> stores, was also impaired, albeit to a lesser extent. Furthermore, ribosomal proteins were massively dysregulated, and protein synthesis was impeded upon Rab10 depletion. Finally, the DCV exocytosis deficit in Rab10 KD neurons was largely rescued by leucine supplementation. We conclude that the strong inhibition of DCV exocytosis upon Rab10 depletion is mostly due to protein synthesis deficiency and to a lesser extent by dysregulation of Ca<sup>2+</sup> channels or internal Ca<sup>2+</sup> stores.</p><sec id="s3-1"><title>Rab10 regulates neurite outgrowth but not membrane homeostasis in mature neurons</title><p>Rab10 is highly enriched in neurons and plays crucial roles in neuronal development (<xref ref-type="bibr" rid="bib70">Taylor et al., 2015</xref>; <xref ref-type="bibr" rid="bib75">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="bib77">Xu et al., 2014</xref>). Consistent with these previous findings, we observed a reduction of axonal and dendritic outgrowth in Rab10-depleted neurons. Also consistent with previous findings in invertebrates (<xref ref-type="bibr" rid="bib61">Sasidharan et al., 2012</xref>), we observed that the endogenous levels of SV markers remain unchanged, indicating that SV biogenesis was unaffected. However, morphological characterization of neurons infected with shRNAs after the first week in culture did not identify changes in the total length of dendrites or axons, indicating that membrane homeostasis in mature neurons was unaffected by Rab10 knockdown. Therefore, the strong deficit in neuropeptide release in DIV7-infected neurons is unlikely to be confounded by Rab10-dependent aspects of neuronal development.</p></sec><sec id="s3-2"><title>Rab10 is crucial for DCV exocytosis</title><p>In <italic>C. elegans</italic>, neuropeptide release was abolished in Rab10 deletion mutants (<xref ref-type="bibr" rid="bib61">Sasidharan et al., 2012</xref>). We observed a 60% reduction in neuropeptide release in Rab10-depleted mature mouse hippocampal neurons. The difference in effect size could be explained by the incomplete Rab10 depletion with shRNA silencing or by redundant pathways in mammals, e.g., Rab10 and Rab8 are closely related paralogs and share many common effectors (<xref ref-type="bibr" rid="bib34">Homma et al., 2021</xref>).</p><p>Unlike Rab3, which travels together DCVs and exhibits a reduction of over 90% in DCV exocytosis in its quadruple knockout neurons (<xref ref-type="bibr" rid="bib56">Persoon et al., 2019</xref>), Rab10 does not typically travel with DCVs (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). In addition, no changes in DCV size, puncta intensity, puncta distribution, travel velocity, or distance were detected in Rab10 KD neurons. We conclude that DCV exocytosis deficiency in Rab10-depleted neurons is not caused by alterations in DCV biogenesis or transport and that Rab10 is not required for DCV trafficking.</p><p>Although Rab10 is found in subcellular fractions enriched in SVs (<xref ref-type="bibr" rid="bib68">Takamori et al., 2006</xref>; <xref ref-type="bibr" rid="bib69">Taoufiq et al., 2020</xref>), it is dispensable for SV exocytosis. Evoked postsynaptic currents were unaffected in Rab10 mutants in <italic>C. elegans</italic> (<xref ref-type="bibr" rid="bib61">Sasidharan et al., 2012</xref>). In line with this, SV exocytosis was unaffected in Rab10-depleted hippocampal neurons. These results indicate that Rab10 is selectively required for DCV exocytosis, not for SV exocytosis. Strikingly, many synaptic proteins, including many involved in SV exocytosis, are among the most severely dysregulated proteins upon Rab10 depletion. SV exocytosis may be more resilient to acute protein changes (<xref ref-type="bibr" rid="bib66">Sinha et al., 2011</xref>) than DCVs. In addition, vesicle secretion properties are different for DCVs and SVs. Unlike SVs, which are secreted upon a single electrical stimulation, DCVs need prolonged or more intense stimulation for the induction of fusion. Thus, the regulatory effects of Rab10 on DCV exocytosis might be amplified under prolonged stimulation.</p></sec><sec id="s3-3"><title>Ca<sup>2+</sup> homeostasis deficits contribute to DCV exocytosis deficits in Rab10 KD neurons</title><p>Rab10 KD neurons showed depleted ER Ca<sup>2+</sup> and impaired cytosolic Ca<sup>2+</sup> responses. These effects may contribute to the observed DCV exocytosis deficits. Ca<sup>2+</sup> released from the ER promotes DCV mobility and potentiates neuropeptide release via activating the CaMKII pathway in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib64">Shakiryanova et al., 2007</xref>). However, this might not be the case in mouse neurons since most axonal ER takes Ca<sup>2+</sup> up from cytosol, instead of releasing it (<xref ref-type="bibr" rid="bib16">de Juan-Sanz et al., 2017</xref>). Second, triggering Ca<sup>2+</sup> release from the ER did not alter DCV transport and fusion (unpublished data from our lab). Finally, a previous study from our lab has shown that CaMKII deficiency does not alter DCV exocytosis (<xref ref-type="bibr" rid="bib48">Moro et al., 2020</xref>). Hence, dysregulation of ER Ca<sup>2+</sup> dynamics may not directly explain the observed DCV exocytosis deficits in Rab10-depleted neurons. However, ER Ca<sup>2+</sup> also regulates Ca<sup>2+</sup> influx by modulating L-type voltage-gated Ca<sup>2+</sup> channels at the plasma membrane via an STIM1-based feedback loop (<xref ref-type="bibr" rid="bib16">de Juan-Sanz et al., 2017</xref>). Given the importance of Ca<sup>2+</sup> influx for DCV exocytosis, dysregulation of ER Ca<sup>2+</sup> dynamics may indirectly explain DCV exocytosis deficiency upon Rab10 depletion. However, ionomycin-triggered DCV exocytosis, which bypasses voltage-gated Ca<sup>2+</sup> channels, was still reduced, albeit to a lesser extent compared to AP trains. This difference in effect size is consistent with a limited contribution for dysregulation of Ca<sup>2+</sup> dynamics and voltage-gated Ca<sup>2+</sup> channels to explain the impaired DCV exocytosis in Rab10 KD neurons, while the majority of this phenotype is explained by deficits downstream of protein synthesis.</p></sec><sec id="s3-4"><title>A role of Rab10 in protein synthesis largely explains DCV exocytosis deficiency in Rab10 KD neurons</title><p>In line with the previous study (<xref ref-type="bibr" rid="bib45">Lv et al., 2015</xref>), which indicated alteration in ER morphology in Rab10 KO embryonic cells. We observed impaired ER morphology and upregulated ribosomal proteins upon Rab10 depletion. The upregulation of ribosomal proteins might be a compensatory response to altered ER structure as mutation of other ER-shaping proteins, such as VCP and ALT1, causes similar ribosomal abnormalities as Rab10 depletion (<xref ref-type="bibr" rid="bib65">Shih and Hsueh, 2016</xref>). Protein homeostasis is vital for neuronal function, and deficiency in protein translation is related to several CNS disorders (<xref ref-type="bibr" rid="bib12">Cajigas et al., 2010</xref>; <xref ref-type="bibr" rid="bib33">Holt et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Koga et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Laguesse and Ron, 2020</xref>).</p><p>Dysregulation of ribosomes and ER is probably sufficient to explain the impaired protein translation in Rab10 KD neurons. Depleted ER Ca<sup>2+</sup> may induce ER stress (<xref ref-type="bibr" rid="bib5">Arruda and Hotamisligil, 2015</xref>; <xref ref-type="bibr" rid="bib25">Fu et al., 2011</xref>), which may also contribute to protein translation inhibition, but ATF4 levels are unaffected in Rab10 KD neurons, suggesting that ER stress is at best limited (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A and B</xref>). In addition, Rab10 regulates the retrograde transport of TrkB signaling endosomes (<xref ref-type="bibr" rid="bib43">Lazo and Schiavo, 2023</xref>), which may activate the CREB/mTOR pathway and promote protein synthesis (<xref ref-type="bibr" rid="bib50">Moya-Alvarado et al., 2023</xref>). Hence, impaired TrkB transport may also contribute to impaired protein translation in addition to dysregulated ribosomes in Rab10 KD neurons. We found that restoring protein synthesis with leucine efficiently increased protein synthesis and largely restored DCV exocytosis deficiency in Rab10-depleted neurons. We conclude that dysregulation of protein synthesis results in DCV exocytosis deficits in these neurons.</p><p>In conclusion, our data demonstrate the importance of Rab10 in neuropeptide release and ER homeostasis. We observed altered ER morphology, reduced ER Ca<sup>2+</sup> concentration, impaired protein synthesis, and impaired neuropeptide release in Rab10-depleted neurons. These observations shed light on the pathogenesis of Rab10-related disease. In addition, we have shown that leucine can largely rescue deficiency in protein synthesis and neuropeptide release in Rab10-depleted neurons, providing a potential treatment for disorders associated with neuropeptide abnormalities such as depression and anxiety.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Rab10</italic></td><td align="left" valign="bottom">NCBI</td><td align="left" valign="bottom">74173</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J</td><td align="left" valign="bottom">Charles River</td><td align="left" valign="bottom">Strain code 631</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Rattus norvegicus</italic>)</td><td align="left" valign="bottom">Wistar (Crl:WI)</td><td align="left" valign="bottom">Charles River</td><td align="left" valign="bottom">Strain code 003</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">MAP2 (chicken polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab5392<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2138153">AB_2138153</ext-link></td><td align="left" valign="bottom">1:200 (IF)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">SMI312 (mouse polyclonal)</td><td align="left" valign="bottom">Eurogentec</td><td align="left" valign="bottom">SMI-312P-050</td><td align="left" valign="bottom">1:500 (IF)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Synaptophysin 1 (guinea pig polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">101004<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_1210382">AB_1210382</ext-link></td><td align="left" valign="bottom">1:500 (IF)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">KDEL (mouse monoclonal)</td><td align="left" valign="bottom">Enzo Life Sciences</td><td align="left" valign="bottom">ADI-SPA-827-D<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2039327">AB_2039327</ext-link></td><td align="left" valign="bottom">1:200 (IF)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">RTN4 (rabbit polyclonal)</td><td align="left" valign="bottom">Novus Biologicals</td><td align="left" valign="bottom">NB100-56681<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_838641">AB_838641</ext-link></td><td align="left" valign="bottom">1:200 (IF)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">SERCA2 (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">sc-376235<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_10989947">AB_10989947</ext-link></td><td align="left" valign="bottom">1:200 (IF)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rab10 (rabbit polyclonal)</td><td align="left" valign="bottom">Protein Tech</td><td align="left" valign="bottom">11808-1-AP<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2173442">AB_2173442</ext-link></td><td align="left" valign="bottom">1:2000 (WB)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rab10 (mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab104859<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_10711207">AB_10711207</ext-link></td><td align="left" valign="bottom">1:2000 (WB)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Actin (mouse monoclonal)</td><td align="left" valign="bottom">Chemicon</td><td align="left" valign="bottom">MAB1501<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2223041">AB_2223041</ext-link></td><td align="left" valign="bottom">1:4000 (WB)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Puromycin (mouse monoclonal)</td><td align="left" valign="bottom">Bio Connect</td><td align="left" valign="bottom">MABE343<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2566826">AB_2566826</ext-link></td><td align="left" valign="bottom">1:2500 (WB)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Phospho-p70 S6 Kinase (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">9234S<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2269803">AB_2269803</ext-link></td><td align="left" valign="bottom">1:1000 (WB)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">p70 S6 kinase (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">9202S<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_331676">AB_331676</ext-link></td><td align="left" valign="bottom">1:1000 (WB)</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">shRNA#9</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">Lentiviral construct to transfect and express the shRNA (see Materials and methods)</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">shRNA#11</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">Lentiviral construct to transfect and express the shRNA (see Materials and methods)</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Control</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">Lentiviral construct to transfect and express the control (see Materials and methods)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pLenti-Syn(pr)-NPY-pHluorin</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31679900">31679900</ext-link></td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pLenti-Syn(pr)-NPY-mCherry</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31679900">31679900</ext-link></td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pLenti-Syn(pr)-Synaptophysin-pHluorin</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34020952">34020952</ext-link></td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pLenti-Syn(pr)-Synaptophysin-GCaMP6</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">Generation of this reagent is described in Materials and methods</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">ER-GCaMP6-150</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_86918">Addgene_86918</ext-link></td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">mCherry-ER3</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_55041">Addgene_55041</ext-link></td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">EGFP-Rab10T23N</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_86918">Addgene_86918</ext-link></td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">pLenti-Syn(pr)- Rab10-EGFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">Generation of this reagent is described in Materials and methods</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">2.5% trypsin</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">15090046</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Poly-L-ornithine</td><td align="left" valign="bottom">Worthington Biochemical Corporation</td><td align="left" valign="bottom">LS003127</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Laminin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">L2020</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Poly-D-lysine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">P6407</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">L-Leucine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">L8000</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Tunicamycin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">T7765-10MG</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Puromycin</td><td align="left" valign="bottom">Merck/Millipore</td><td align="left" valign="bottom">540222-25MG</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Ionomycin</td><td align="left" valign="bottom">Fisher Emergo</td><td align="left" valign="bottom">10429883</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TCE</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">115-20-8</td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MATLAB</td><td align="left" valign="bottom">MathWorks</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_001622">SCR_001622</ext-link></td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom">–</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Fiji/ImageJ</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002285">SCR_002285</ext-link></td><td align="left" valign="bottom">–</td></tr></tbody></table><table-wrap-foot><fn><p>WB: western blot; IF: immunofluorescence.</p></fn></table-wrap-foot></table-wrap><sec id="s4-1"><title>Laboratory animals and primary cultures</title><p>All animals were bred and housed according to Institutional and Dutch governmental guidelines and regulations. The primary neuronal culture was done as described before (<xref ref-type="bibr" rid="bib49">Moro et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Persoon et al., 2019</xref>). Briefly, hippocampi or cortices were extracted from E18 WT embryos in Hanks’ Balanced Salt Solution (Sigma-Aldrich), supplemented with 10 mM HEPES (Gibco) and were digested with 0.25% trypsin (Gibco) for 20 min at 37°C. Neurons were washed three times and dissociated with fire-polished Pasteur pipettes. Dissociated neurons were spun down at 1000 rpm for 5 min and resuspended in Neurobasal Medium (Gibco) supplemented with 2% B-27 (Gibco), 1.8% HEPES, 0.25% GlutaMAX (Gibco), and 0.1% penicillin/streptomycin. For continental culture, hippocampal neurons were plated at a density of 30,000 on pre-grown rat glia cells, generated by adding 25,000 glia cells on 18 mm glass coverslips coated with 0.1 mg/ml poly-d-lysine (Sigma-Aldrich) in 12-well plates. For island culture, a density of 1500 hippocampal neurons was plated on pre-grown microglia islands, generated by plating 6000 glia cells on 18 mm glass coverslips coated with agarose and stamped with a solution of 0.1 mg/ml poly-d-lysine (Sigma-Aldrich) and 0.7 mg/ml rat tail collagen (BD Biosciences). For western blot (WB), cortical neurons were plated at a density of 300,000 on six-well plates coated with a solution of 0.0005% poly-l-ornithine and laminin (2.5 μg/ml) (Sigma-Aldrich). Neurons were kept in supplemented Neurobasal at 37°C and 5% CO<sub>2</sub> for 14–16 days (DIV14–16).</p></sec><sec id="s4-2"><title>Plasmid and lentiviral infection</title><p>NPY-pHluorin, NPY-mCherry, and Synaptophysin-pHluorin plasmids have been described (<xref ref-type="bibr" rid="bib56">Persoon et al., 2019</xref>). Synaptophysin-GCaMP6 was generated by adding GCaMP6 to the C-terminus of the mouse sequence of synaptophysin as previously reported (<xref ref-type="bibr" rid="bib16">de Juan-Sanz et al., 2017</xref>). ER-GCaMP6-150, mCherry-ER3, and Rab10T23N were purchased from Addgene (ER-GCaMP6-150: #86918; mCherry-ER3: #55041; Rab10T23N: #49545). Rab10-EGFP construct was obtained from a mouse cDNA library by PCR and labeled with EGFP at the C-terminus. The target sequences of shRNA are as follows: <named-content content-type="sequence">CGATGCCTTCAATACCACCTT</named-content> (shRNA#9), <named-content content-type="sequence">GAGAGTTGTACCGAAAGGCAA</named-content> (shRNA#11), TTC <named-content content-type="sequence">TCCGAACGTGTCACGT</named-content> (control, scramble), <named-content content-type="sequence">CGATGCATTTAACACAACCTT</named-content> (Rab10 resistant to shRNA#9).</p><p>All plasmids were sequence-verified and packed into lentiviral particles as described previously (<xref ref-type="bibr" rid="bib51">Naldini et al., 1996</xref>).</p></sec><sec id="s4-3"><title>Immunocytochemistry</title><p>Neurons were fixed at DIV14–16 in freshly prepared 3.7% paraformaldehyde (EMS) for 20 min at room temperature and permeabilized with 0.5% Triton X-100 (Fisher Chemical) for 5 min, blocked with 0.1% Triton X-100 and 2% normal goat serum for 30 min. Incubation with primary antibodies was done at room temperature for 2 hr or overnight at 4°C. After three times of phosphate-buffered saline (PBS) washing, neurons were incubated with Alexa Fluor-conjugated secondary antibodies (1:1000; Invitrogen) for 1 hr at room temperature. Coverslips were mounted in Mowiol (Sigma-Aldrich) and imaged on a Zeiss LSM 510 confocal laser-scanning microscope (×40 objective; NA 1.3) with LSM510 software (version 3.2 Zeiss) or on an A1R Nikon confocal microscope with LU4A laser unit (×40 objective; NA 1.3) with NIS-Elements software (version 4.60, Nikon). Images were acquired as Z-stack at a step of 0.5 μm. All acquisition settings were kept constant for scans within each experiment. All solutions were in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na<sub>2</sub>HPO<sub>4</sub>, 1.8 mM KH<sub>2</sub>PO<sub>4</sub>, pH 7.4). Primary antibodies used were: MAP2 (Abcam 1:200), SMI312 (Eurogentec, 1:500), synaptophysin 1 (SySy, 1:500), KDEL (Enzo Life Sciences, 1:200), RTN4 (NB100-56681, 1:200), ATF4 (CST, 1:200). To measure ATF4 intensity, neurons were treated with 5 μg/ml tunicamycin (TM; Sigma-Aldrich) or DMSO as vehicle for 24 hr before fixation. Analysis of staining intensity was done with ImageJ. Analysis of neuronal morphology, synapses, or DCV number was performed using the custom-made software SynD (<xref ref-type="bibr" rid="bib63">Schmitz et al., 2011</xref>).</p></sec><sec id="s4-4"><title>Western blotting</title><p>Cortical neurons were lysed at DIV14. Lysates were run on a 10% SDS-PAGE gel and transferred to a polyvinylidene difluoride membrane (Bio-Rad). Membranes were blocked with 5% milk (Merck) in PBS with 0.1% Tween 20 for 1 hr at room temperature and incubated in primary antibodies overnight at 4°C. Secondary alkaline phosphatase-conjugated antibodies (1:10,000; Jackson ImmunoResearch) were incubated for 50 min at room temperature. Membranes were visualized with AttoPhos (Promega) and scanned with an FLA-5000 fluorescent image analyzer (Fujifilm). Band intensities of interests were analyzed using Fiji and normalized to the intensity of a loading control (actin).</p><p>For de novo-synthesized proteins quantification, surface sensing of translation (SUnSET) was performed as previously described (<xref ref-type="bibr" rid="bib62">Schmidt et al., 2009</xref>). In brief, neurons were incubated with 2 μM puromycin (InvivoGen) for 30 min before harvesting lysates. Puromycinylated proteins were detected with the anti-puromycin antibody by WB. To measure the total protein level, 2,2,2-trichloroethanol (TCE, Lot # BCBK5461V, Sigma-Aldrich) was dissolved in the gel buffer (0.5%) and gels were scanned with Gel Doc EZ Imager (Bio-Rad).</p><p>Antibodies used for WB: actin (1:4000; Chemicon), SERCA2 (Santa Cruz, 1:1000), Rab10 (Proteintech, 1:2000), Rab10 (Abcam, 1:2000), Puromycin (Bio Connect, 1:2500), Phospho-p70 S6 kinase (Cell Signaling Technology, 1:1000), p70 S6 kinase (Cell Signaling Technology, 1:1000).</p></sec><sec id="s4-5"><title>Proteomics</title><p>DIV14 cortical neurons were prepared as previously described (<xref ref-type="bibr" rid="bib28">Gonzalez-Lozano et al., 2019</xref>). In brief, neurons were washed three times with ice-cold PBS. Then, 500 μl PBS supplemented with a protease inhibitor cocktail (Roche) was added to each well and neurons were collected by gentle scraping. Neurons were centrifuged for 5 min at 3000×<italic>g</italic> at 4°C and the pellet was collected and lysed in Laemmli Loading Buffer (4% SDS, 100 mM Tris pH 6.8, 200 mM DTT, 20% glycerol, 0.04% bromophenol blue). In-gel digestion was performed overnight at 37°C with MS grade endo Trypsin/LysC (Promega). The digested peptides were dried using a SpeedVac and stored at − 20°C until further processing. An SDS-PAGE LC-MS/MS approach was used for peptide identification as previously reported. SWATH data were analyzed using Spectronaut 8.0. The spectral library was created from the merging of two data-dependent analyses of non-transfected hippocampal neuron culture and hippocampal synaptosomes containing spike-in iRT peptides from Biognosys. The retention time prediction was set to dynamic iRT; the cross-run normalization based on total peak areas was enabled. Peptide abundances were exported and analyzed using R language for statistical computation. Only peptides present in both control and transfected groups and quantified with high confidence were included (i.e. q-value≤10<sup>−3</sup> over all samples in either group, allowing for one outlier within each condition). Protein abundances were computed using Spectronaut normalized peak area, and Loess normalized using the ‘normalizeCyclicLoess’ function from the limma R package (fast method and 10 iterations). Proteins with an adjusted FDR≤0.01 and log2 fold change≥0.56 were defined as significant hints. The proteomics experiment presented in <xref ref-type="fig" rid="fig3">Figure 3</xref> was conducted with two independent cultures with four technical replicates for each condition. For the analysis, we only included peptides that were consistently detected across all samples.</p></sec><sec id="s4-6"><title>Bioinformatics</title><p>GO analysis on proteomics data was performed with Cytoscope plug-in ClueGO (<xref ref-type="bibr" rid="bib10">Bindea et al., 2009</xref>). The following settings were used for the biological process analysis in ClueGO: Biological process (update: May 25, 2022), GO term grouping, GO tree interval was set 6–10, GO term consists of min. 3 genes and min. 3% of the term. The GO fusion option was set as true with a threshold of 50%. GO terms were grouped with a Kappa score threshold of 0.4 and named after the most significant GO term. Cellular component analysis: Cellular component analysis (update: May 25, 2022), GO term grouping, GO tree interval was set 6–8, GO term consists of min. 5 genes and min. 5% of the term. The GO fusion option was set as true with a threshold of 50%. GO terms were grouped with a Kappa score threshold of 0.5 and named after the most significant GO term. All detected proteins were input as background. GO analysis of synaptic proteins was done with SynGO as previously described (<xref ref-type="bibr" rid="bib39">Koopmans et al., 2019</xref>).</p></sec><sec id="s4-7"><title>Electron microscopy</title><p>Hippocampal neurons plated on coated plates were infected with control or shRNA#9 at DIV7 and fixed at DIV14 with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4). Samples were post-fixed for 1 hr at room temperature in 1% osmium/1% ruthenium. After dehydration by increasing ethanol concentrations (30%, 50%, 70%, 90%, 96%, and 100%), cells were embedded in EPON solution and polymerized for 72 hr at 65°C. Glass coverslips were removed by heating the sample with hot water. Regions with a high density of neurons were selected under light microscopy and mounted on pre-polymerized EPON blocks. Ultrathin sections (70–90 nm) were cut parallel to the cell monolayer and collected on single-slot, formvar-coated copper grids, and stained in uranyl acetate and lead citrate (Leica EM AC20). Sections were imaged in a JEOL1010 transmission electron microscope (JEOL) at 60 kV while being blinded for the experimental conditions. Synapses, somas, and DCV-rich areas were photographed by a side-mounted Modera camera (EMSIS GmbH). For all synaptic analyses, only synapses with intact synaptic plasma membranes with a recognizable pre- and postsynaptic density and clear SV membranes were selected. DCV and ER diameters were measured in iTEM software (Olympus) and synapse parameters were quantified in a custom-written software running in MATLAB (MathWorks) while being blinded for the experimental conditions.</p></sec><sec id="s4-8"><title>Live-cell imaging</title><p>Neurons at DIV14–16 were transferred to an imaging chamber and perfused with Tyrode’s solution (2 mM CaCl<sub>2</sub>, 2.5 mM KCl, 119 mM NaCl, 2 mM MgCl<sub>2</sub>, 30 mM glucose, 25 mM HEPES; pH 7.4). Imaging was acquired on a custom-build microscope (AxioObserver.Z1, Zeiss) with ×40 oil objective (NA 1.3) and an EM-CCD camera (C9100-02; Hamamatsu, pixel size 200 nm) unless otherwise specified. Electrode field stimulation was applied using a stimulus generator (A-385, World Precision Instruments) controlled by a Master-8 (AMPI) to deliver 1 ms pulses of 30 mA. Experiments were performed at room temperature.</p><p>For SypHy experiments, neurons were imaged for 30 s as a baseline and then stimulated with electrical field stimulation for 5 s at 40 Hz. After 90 s, neurons were superfused with modified Tyrode’s solution containing NH<sub>4</sub>Cl (2 mM CaCl<sub>2</sub>, 2.5 mM KCl, 119 mM NaCl, 2 mM MgCl<sub>2</sub>, 30 mM glucose, 25 mM HEPES, and 50 mM NH<sub>4</sub>Cl (pH 7.4)) delivered by gravity flow through a capillary placed above the neurons.</p><p>SV fusion analysis was performed as described previously (<xref ref-type="bibr" rid="bib49">Moro et al., 2021</xref>). Briefly, regions of interest (ROIs) consisting of 6×6 pixels were placed on individual synapses identified as increased signals after the NH<sub>4</sub>Cl perfusion. Individual traces were analyzed using a custom-made MATLAB (MathWorks) script. Synapses were quantified as active if the maximum ΔF/F0 value upon stimulation was ≥3 * StD(F0). Active synapses were pooled per neuron. SV fusion fraction was calculated as the ΔFstimulation/ΔF NH<sub>4</sub>Cl.</p><p>For DCV fusion experiments, the imaging included 30 s of baseline recording and then stimulated with electrical field stimulation for 16 pulses of 50 AP at 50 Hz. Chemical stimulation of 5 μM ionomycin (Fisher Emergo), dissolved in modified Tyrode’s solution, was applied through glass capillaries placed near the neuron by gravity flow. After 90 s, neurons were superfused with modified Tyrode’s solution containing NH<sub>4</sub>Cl. For the leucine rescue experiment, neurons expressing NPY-pHluorin were treated with 5 mM leucine 3 days before live-cell imaging or with DMSO as a control.</p><p>DCV fusion events were analyzed as described previously (<xref ref-type="bibr" rid="bib56">Persoon et al., 2019</xref>). Briefly, DCV fusion events were detected by a rapid increase in fluorescence intensity. ROIs consisting of 3×3 pixels were placed on the time-lapse recordings using a custom-made script in Fiji. Resulting traces were evaluated using a custom-made script in MATLAB, and only events with F/F0≥2 SD and a rise time of less than 1 s were recorded. F0 was calculated by averaging the first 10 frames of the time-lapse recording. The total intracellular DCV pool was determined as the number of fluorescent puncta after the superfusion of Tyrode’s solution containing 50 mM NH<sub>4</sub>Cl. The released fraction was calculated by dividing the number of fusion events per neuron by the total intracellular pool of DCVs.</p><p>For DCV transport experiments, neurons were imaged at DIV14 in time-lapse recordings (2 Hz) at room temperature. Stacks were divided into 10×10 regions with the Grid function in ImageJ, and transport was measured in five random regions (coordinates generated by random number generation in MATLAB). Kymographs were generated in ImageJ (MultipleKymograph, line width 3) and were analyzed with a deep learning-based software (KymoButler) as previously described (<xref ref-type="bibr" rid="bib35">Jakobs et al., 2019</xref>).</p></sec><sec id="s4-9"><title>Ca<sup>2+</sup> imaging</title><p>For cytosolic Ca<sup>2+</sup> imaging, neurons were incubated with 1 µM Fluo-5F AM (Molecular Probes, F14222; stock in DMSO) for 10 min at 37°C. For data shown in <xref ref-type="fig" rid="fig6">Figure 6D, E, and F</xref>, neurons were perfused with normal Tyrode’s solution and stimulated with the same pattern used for DCV experiments.</p><p>For the caffeine-induced Ca<sup>2+</sup> responses (<xref ref-type="fig" rid="fig5">Figure 5</xref>), neurons were perfused with Tyrode’s solution without Ca<sup>2+</sup>. Fluorescent intensity in soma was measured with ImageJ. Normalized ΔF/F0 data was calculated per neuron after background subtraction.</p><p>For synaptic Ca<sup>2+</sup> imaging, neurons were infected with Synaptophysin-GCaMP6 at DIV8 and imaged at DIV14. Neurons were perfused with normal Tyrode’s solution and stimulated with the same pattern used for DCV experiments. 20 neurite-located ROIs (6×6 pixels) and a background ROI were measured per cell. Normalized ΔF/F0 data was calculated per neuron after background subtraction.</p><p>For ER Ca<sup>2+</sup> measurement, neurons were infected with ER-GCAMP6-150 at DIV8 and were imaged at DIV14 at room temperature. As previously described (<xref ref-type="bibr" rid="bib16">de Juan-Sanz et al., 2017</xref>), 500 µM or 50 µM ionomycin was applied to saturate the ER-GCAMP6-150 signal in soma or neurite, respectively. [Ca<sup>2+</sup>]<sub>ER</sub> were calculated as follows: [Ca<sup>2+</sup>]<sub>ER</sub>=Kd((Fr/Fmax−1/Rf)/(1−Fr/Fmax)<sup>1/</sup>n). Kd is the affinity constant of the indicator (150 μM), Fr is the measured fluorescence at rest, Rf is the dynamic range (45), and n is the Hill coefficient (1.6). Fmax values were not corrected for pH changes.</p><p>All Ca<sup>2+</sup> imaging experiments were performed in an imaging buffer with an epifluorescence microscope (Nikon Eclipse Ti) equipped with a ×40 oil objective. Quantitative analysis and image processing were performed using ImageJ.</p></sec><sec id="s4-10"><title>Fluorescence recovery after photobleaching</title><p>Neurons were infected with mCherry-ER3 at DIV9 and imaged at DIV14 on a Nikon Ti-E Eclipse inverted microscope controlled by NIS-Elements software. The acquisition was performed with a ×40 oil objective. After acquiring 10 pre-FRAP images (every 8.5 s), an 80-pixel long ROI on the proximal axon was photobleached with maximal laser power (10 iterations). Images were acquired for 300 s. The post-bleaching fluorescence intensity was normalized to the baseline fluorescence (F0), which was defined as the average intensity of 10 frames before the onset of photobleaching.</p></sec><sec id="s4-11"><title>Statistics</title><p>All data are presented as mean ± s.e.m. Datasets on single neuron measurements consist of several neuronal cultures (N=number of independent cultures). Within each culture, different coverslips are infected with various viruses to create distinct experimental groups, from which multiple observations (n=individual neurons) are taken. To account for the nested nature of our datasets, a fixed linear regression was performed, in which culture was included as a linear predictor. Possible outliers were identified using the ROUT method using GraphPad Prism software and were excluded from the statistical analysis. A fixed linear regression model was then fitted to the data using the lm() function in R. A one-way ANOVA (analysis of variance) was used to assess whether including the experimental group as a second linear predictor (formula = y ~ Group + Culture) statistically improved the fit of a model without group information (formula = y ~ 1 + Culture). Post hoc analysis was performed using emmeans() function with Turkey adjustment when more than two experimental groups were present. Full statistical information, including exact p-values, is provided in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Summary of statistical analyses.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Figure</th><th align="left" valign="bottom">Dataset</th><th align="left" valign="bottom">Groups</th><th align="left" valign="bottom">n-number*</th><th align="left" valign="bottom">Statistical test</th><th align="left" valign="bottom">p-value</th></tr></thead><tbody><tr><td align="left" valign="bottom">1 A</td><td align="left" valign="bottom">Band intensity of Rab10</td><td align="left" valign="top">Control ShRNA#9 ShRNA#11 Rescue</td><td align="left" valign="top">4 cultures</td><td align="left" valign="top">One sample t-test (compare to 100%)</td><td align="left" valign="top">P<sub>shRNA#9</sub>=0.0046 (**) P<sub>shRNA#11</sub>&lt;0.0001 (****) P<sub>rescue</sub> =0.5034 (ns)</td></tr><tr><td align="left" valign="top">1 C</td><td align="left" valign="bottom">Dendritic length (MAP2)</td><td align="left" valign="top">Control ShRNA#9</td><td align="left" valign="top">3 (35) 3 (32)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.0093 (**)</td></tr><tr><td align="left" valign="bottom">1D</td><td align="left" valign="bottom">Axonal length (SMI312)</td><td align="left" valign="top">Control ShRNA#9</td><td align="left" valign="top">3 (35) 3 (32)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="bottom">1E</td><td align="left" valign="bottom">Syp1 intensity per synapse per neuron</td><td align="left" valign="top">Control ShRNA#9</td><td align="left" valign="top">3 (35) 3 (32)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.4975 (ns)</td></tr><tr><td align="left" valign="bottom">1 F</td><td align="left" valign="bottom">Syp1-positive synapse density in MAP2-positive dendrites</td><td align="left" valign="top">Control ShRNA#9</td><td align="left" valign="top">3 (35) 3 (32)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.4975 (ns)</td></tr><tr><td align="left" valign="bottom">1 J</td><td align="left" valign="bottom">SypHy fused fraction</td><td align="left" valign="top">Control ShRNA#9</td><td align="left" valign="top">3 (47) 3 (56)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.9496 (ns)</td></tr><tr><td align="left" valign="bottom">1 K</td><td align="left" valign="bottom">Decay content</td><td align="left" valign="top">Control ShRNA#9</td><td align="left" valign="top">3 (47) 3 (56)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.2910 (ns)</td></tr><tr><td align="left" valign="top" rowspan="2">2B</td><td align="left" valign="top" rowspan="2">Dendritic length (MAP2)</td><td align="left" valign="top" rowspan="2">Control ShRNA#9 ShRNA#11</td><td align="left" valign="top" rowspan="2">3 (31) 3 (28) 3 (31)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>=0.1818 (ns)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs ShRNA#9</sub>=0.9771 (ns); p<sub>Control vs ShRNA#11</sub>=0.3004 (ns); p <sub>ShRNA#9 vs ShRNA#11</sub>=0.2276 (ns);</td></tr><tr><td align="left" valign="top" rowspan="2">2 C</td><td align="left" valign="top" rowspan="2">Axonal length (SMI312)</td><td align="left" valign="top" rowspan="2">Control ShRNA#9 ShRNA#11</td><td align="left" valign="top" rowspan="2">3 (31) 3 (28) 3 (31)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>=0.0936 (ns)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs ShRNA#9</sub>=0.5037 (ns); p<sub>Control vs ShRNA#11</sub>=0.5313 (ns); p <sub>ShRNA#9 vs ShRNA#11</sub>=0.0823 (ns);</td></tr><tr><td align="left" valign="top" rowspan="2">2D</td><td align="left" valign="top" rowspan="2">Syp1-positive synapse density in MAP2-positive dendrites</td><td align="left" valign="top" rowspan="2">Control ShRNA#9 ShRNA#11</td><td align="left" valign="top" rowspan="2">3 (31) 3 (28) 3 (31)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>=0.2126 (ns)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs ShRNA#9</sub>=0.3405 (ns); p<sub>Control vs ShRNA#11</sub>=0.9788 (ns); p <sub>ShRNA#9 vs ShRNA#11</sub>=0.2503 (ns);</td></tr><tr><td align="left" valign="top" rowspan="2">2I</td><td align="left" valign="top" rowspan="2">DCV fusion events/neuron</td><td align="left" valign="top" rowspan="2">Control ShRNA#9 ShRNA#11 Rescue</td><td align="left" valign="top" rowspan="2">3 (36) 3 (37) 3 (30) 3 (34)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs ShRNA#9</sub>=0.0450 (*); p<sub>Control vs ShRNA#11</sub>=0.0105 (**); p <sub>ShRNA#11vs Rescue</sub>=0.0021 (**); p<sub>ShRNA#9 vs Rescue</sub>=0.0100 (*);</td></tr><tr><td align="left" valign="top" rowspan="2">2 J</td><td align="left" valign="top" rowspan="2">Total DCV pool/neuron</td><td align="left" valign="top" rowspan="2">Control ShRNA#9 ShRNA#11 Rescue</td><td align="left" valign="top" rowspan="2">3 (36) 3 (37) 3 (30) 3 (34)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>=0.1014 (ns)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs ShRNA#9</sub>=0.7669 (ns); p<sub>Control vs ShRNA#11</sub>=0.0584 (ns); p <sub>ShRNA#11vs Rescue</sub>=0.4978 (ns); p<sub>ShRNA#9 vs Rescue</sub>=0.9969 (ns);</td></tr><tr><td align="left" valign="top" rowspan="2">2 K</td><td align="left" valign="top" rowspan="2">DCV fusion fraction</td><td align="left" valign="top" rowspan="2">Control ShRNA#9 ShRNA#11 Rescue</td><td align="left" valign="top" rowspan="2">3 (36) 3 (37) 3 (30) 3 (34)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs ShRNA#9</sub>=0.0014 (**); p<sub>Control vs ShRNA#11</sub>=0.0001 (****); p<sub>Control vs Rescue</sub>=0.9902 (ns); p<sub>ShRNA#9 vs Rescue</sub>&gt;0.0048 (**);</td></tr><tr><td align="left" valign="top" rowspan="2">2 suppl 1D</td><td align="left" valign="top" rowspan="2">DCV fusion events/neuron</td><td align="left" valign="top" rowspan="2">Control Rab10 KD Rescue</td><td align="left" valign="top" rowspan="2">3 (26) 3 (47) 3 (22)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.001 (***); p<sub>Control vs Rescue</sub>&gt;0.9999 (ns); p<sub>Rab10 KD vs Rescue</sub>=0.0008 (***);</td></tr><tr><td align="left" valign="top" rowspan="2">2 suppl 1E</td><td align="left" valign="top" rowspan="2">Total DCV pool/neuron</td><td align="left" valign="top" rowspan="2">Control Rab10 KD Rescue</td><td align="left" valign="top" rowspan="2">3 (26) 3 (47) 3 (22)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>=0.0021</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.0098(**); p<sub>Control vs Rescue</sub>=0.9699 (ns); p<sub>Rab10 KD vs Rescue</sub>=0.0138 (*);</td></tr><tr><td align="left" valign="top" rowspan="2">2 suppl 1 F</td><td align="left" valign="top" rowspan="2">DCV fusion fraction</td><td align="left" valign="top" rowspan="2">Control Rab10 KD Rescue</td><td align="left" valign="top" rowspan="2">3 (26) 3 (47) 3 (22)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>&lt;0.002 (**)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.0435 (*); p<sub>Control vs Rescue</sub>=0.6189 (ns); p<sub>Rab10 KD vs Rescue</sub>=0.0031 (**);</td></tr><tr><td align="left" valign="top">2 suppl 2B</td><td align="left" valign="top">DCV transport velocity</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (18) 3 (17)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.8028(ns)</td></tr><tr><td align="left" valign="top">2 suppl 2 C</td><td align="left" valign="top">DCV transport distance</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (18) 3 (17)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.9131 (ns)</td></tr><tr><td align="left" valign="top">2 suppl 2 H</td><td align="left" valign="top">Baseline NPY-phluorin intensity</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (37) 3 (35)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.2734 (ns)</td></tr><tr><td align="left" valign="top">2 suppl 2I</td><td align="left" valign="top">NPY-phluorin fusion intensity</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (37) 3 (35)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.3385 (ns)</td></tr><tr><td align="left" valign="bottom">4 C</td><td align="left" valign="bottom">Active zone length</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 cultures</td><td align="left" valign="top">Linear mixed model</td><td align="left" valign="top"><italic>P</italic>=0.023 (*)</td></tr><tr><td align="left" valign="bottom">4D</td><td align="left" valign="bottom">PSD length</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 cultures</td><td align="left" valign="top">Linear mixed model</td><td align="left" valign="top"><italic>P</italic>=0.020 (*)</td></tr><tr><td align="left" valign="bottom">4E</td><td align="left" valign="bottom">SV number per synapse</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 cultures</td><td align="left" valign="top">Linear mixed model</td><td align="left" valign="top"><italic>P</italic>=0.746 (ns)</td></tr><tr><td align="left" valign="bottom">4 F</td><td align="left" valign="bottom">SV diameter</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 cultures</td><td align="left" valign="top">Linear mixed model</td><td align="left" valign="top"><italic>P</italic>=0.612 (ns)</td></tr><tr><td align="left" valign="bottom">4 G</td><td align="left" valign="bottom">DCV diameter</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 cultures</td><td align="left" valign="top">Linear mixed model</td><td align="left" valign="top"><italic>P</italic>=0.260 (ns)</td></tr><tr><td align="left" valign="bottom">4I</td><td align="left" valign="bottom">rER diameter</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 cultures</td><td align="left" valign="top">Linear mixed model</td><td align="left" valign="top"><italic>P</italic>&lt;0.001 (***)</td></tr><tr><td align="left" valign="bottom">4 suppl 1B</td><td align="left" valign="bottom">RTN4 intensity</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (18) 3 (18)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="bottom">4 suppl 1 C</td><td align="left" valign="bottom">KDEL intensity</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (18) 3 (18)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="bottom">4 suppl 1D</td><td align="left" valign="bottom">Relative N/S intensity of RTN4</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (18) 3 (18)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.01551 (*)</td></tr><tr><td align="left" valign="bottom">4 suppl 1E</td><td align="left" valign="bottom">Relative N/S intensity of KDEL</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (18) 3 (18)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="bottom">4 suppl 2 C</td><td align="left" valign="bottom">Recovery intensity of mCherry-ER3 after photobleaching at T=220 s</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (23) 3 (23)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="bottom">4 suppl 3B</td><td align="left" valign="bottom">ATF4 intensity</td><td align="left" valign="top">Control Rab10 KD TM</td><td align="left" valign="top">2 (25) 2 (30) 2 (14)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.1874 (ns); p<sub>Control vs TM</sub>&lt;0.0001 (****); p<sub>Rab10 KD vs TM</sub>&lt;0.0001 (****);</td></tr><tr><td align="left" valign="bottom">5B</td><td align="left" valign="bottom">Band intensity of SERCA2</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">4 cultures</td><td align="left" valign="top">One sample t-test (compare to 100%)</td><td align="left" valign="top"><italic>P</italic>=0.0017 (**)</td></tr><tr><td align="left" valign="bottom" rowspan="2">5 C</td><td align="left" valign="bottom" rowspan="2">Somatic ER Ca<sup>2+</sup></td><td align="left" valign="top" rowspan="2">Control Rab10 KD Rescue</td><td align="left" valign="top" rowspan="2">3 (17) 3 (17) 3 (17)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>&lt;0.0001 (****); p<sub>Control vs Rescue</sub>&gt;0.5242 (ns); p<sub>Rab10 KD vs Rescue</sub>&lt;0.0001 (****);</td></tr><tr><td align="left" valign="bottom" rowspan="2">5D</td><td align="left" valign="bottom" rowspan="2">Neuritic ER Ca<sup>2+</sup></td><td align="left" valign="top" rowspan="2">Control Rab10 KD Rescue</td><td align="left" valign="top" rowspan="2">3 (17) 3 (17) 3 (17)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>&lt;0.0001 (****); p<sub>Control vs Rescue</sub>&gt;0.5360 (ns); p<sub>Rab10 KD vs Rescue</sub>&lt;0.0001 (****);</td></tr><tr><td align="left" valign="bottom" rowspan="2">5 H</td><td align="left" valign="bottom" rowspan="2">Recovery intensity of Fluo-5 AM</td><td align="left" valign="top" rowspan="2">Control Rab10 KD GDP-Rab10 Rescue</td><td align="left" valign="top" rowspan="2">3 (23) 3 (24) 3 (10) 3 (24)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>&lt;0.0002 (***)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.0005 (****); p<sub>Control vs Rescue</sub>&gt;0.9999 (ns); p<sub>Rab10 KD vs Rescue</sub>=0.0013 (****); p<sub>Control vs GDP-Rab10</sub>=0.0307 (*);</td></tr><tr><td align="left" valign="bottom">5 suppl 1 C</td><td align="left" valign="bottom">ER Ca<sup>2+</sup> release triggered by caffeine (peak)</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (44) 3 (35)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="bottom">5 suppl 1D</td><td align="left" valign="bottom">ER Ca<sup>2+</sup> release triggered by caffeine (area)</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (44) 3 (35)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.0025 (**)</td></tr><tr><td align="left" valign="bottom">6 C</td><td align="left" valign="bottom">Evoked cytosolic Ca<sup>2+</sup> influx</td><td align="left" valign="top">Control Rab10 KD Rescue</td><td align="left" valign="top">3 (24) 3 (30) 3 (27)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.0062 (**); p<sub>Control vs Rescue</sub>=0.9891 (ns); p<sub>Rab10 KD vs Rescue</sub>=0.0128 (*);</td></tr><tr><td align="left" valign="bottom">6 F</td><td align="left" valign="bottom">Evoked presynaptic Ca<sup>2+</sup> influx</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (33) 3 (27)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.0146 (*)</td></tr><tr><td align="left" valign="bottom">7 C</td><td align="left" valign="bottom">Ionomycin-induced DCV fused fraction</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (20) 3 (21)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.0009 (****)</td></tr><tr><td align="left" valign="bottom">7D</td><td align="left" valign="bottom">Total DCV pool/neuron</td><td align="left" valign="top">Control Rab10 KD</td><td align="left" valign="top">3 (20) 3 (21)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top"><italic>P</italic>=0.8821 (ns)</td></tr><tr><td align="left" valign="bottom">8B</td><td align="left" valign="bottom">Band intensity of puromycin</td><td align="left" valign="top">Control Rab10 KD Rab10T23N KD +Leucine</td><td align="left" valign="top">3 cultures</td><td align="left" valign="top">One sample t-test (compare to 100%)</td><td align="left" valign="top">P<sub>Rab10 KD</sub>=0.0354 (*) P<sub>Rab10 T23N</sub>=0.0053 (**) p<sub>KD+Leucine</sub>=0.1486 (ns)</td></tr><tr><td align="left" valign="bottom" rowspan="2">8E</td><td align="left" valign="bottom" rowspan="2">DCV fused fraction</td><td align="left" valign="top" rowspan="2">Control Control +Leu Rab10 KD Rab10+Leu Rab10 KD +Rab10</td><td align="left" valign="top" rowspan="2">3 (47) 3 (45) 3 (61) 3 (54) 3 (24)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>&lt;0.0001 (****)</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>&lt;0.0001 (****); p<sub>Control + Leu vs Rab10 KD</sub>&lt;0.0001 (****); p<sub>Rab10 KD vs Rab10 KD + Rab10</sub>&lt;0.0001 (****); p<sub>Rab10 KD vs Rab10 KD + Leu</sub>&lt;0.0001 (****); p<sub>control vs Rab10 KD + Leu</sub>=0.577 (ns)</td></tr><tr><td align="left" valign="bottom" rowspan="2">8 F</td><td align="left" valign="bottom" rowspan="2">Total DCV pool/neuron</td><td align="left" valign="top" rowspan="2">Control Control +Leu Rab10 KD Rab10+Leu Rab10 KD +Rab10</td><td align="left" valign="top" rowspan="2">3 (47) 3 (45) 3 (61) 3 (54) 3 (24)</td><td align="left" valign="top">One-way ANOVA</td><td align="left" valign="top"><italic>P</italic>=0.1035</td></tr><tr><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.2484 (ns); p<sub>Control + Leu vs Rab10 KD</sub>&gt;0.9999 (****); p<sub>Rab10 KD vs Rab10 KD + Rab10</sub>&gt;0.9999 (ns); p<sub>Rab10 KD vs Rab10 KD + Leu</sub>&gt;0.9999 (ns); p<sub>control vs Rab10 KD + Leu</sub>&gt;0.9999 (ns)</td></tr><tr><td align="left" valign="bottom">8 suppl 2B</td><td align="left" valign="bottom">KDEL intensity</td><td align="left" valign="top">Control Rab10 KD Rab10+Leu</td><td align="left" valign="top">3 (10) 3 (11) 3 (11)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>&lt;0.0001 (****); p<sub>control vs Rab10 KD + Leu</sub>&lt;0.0001 (****); p<sub>Rab10 KDvs Rab10 KD + Leu</sub>=0.9970(ns);</td></tr><tr><td align="left" valign="bottom">8 suppl 2 C</td><td align="left" valign="bottom">Relative N/S intensity of KDEL</td><td align="left" valign="top">Control Rab10 KD Rab10+Leu</td><td align="left" valign="top">3 (10) 3 (11) 3 (11)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>&lt;0.0001 (****); p<sub>control vs Rab10 KD + Leu</sub>&lt;0.0001 (****); p<sub>Rab10 KDvs Rab10 KD + Leu</sub>=0.9293(ns);</td></tr><tr><td align="left" valign="bottom">8 suppl 3 C</td><td align="left" valign="bottom">DCV fusion events/neuron</td><td align="left" valign="top">Control Rab10 KD SERCA2</td><td align="left" valign="top">2 (10) 2 (13) 2 (15)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.0084 (**); p<sub>Control vs SERCA2</sub> =0.0095 (**); p<sub>rab10 KD vs SERCA2</sub> =0.0095 (**);</td></tr><tr><td align="left" valign="bottom">8 suppl 3D</td><td align="left" valign="bottom">Total DCV pool/neuron</td><td align="left" valign="top">Control Rab10 KD SERCA2</td><td align="left" valign="top">2 (10) 2 (13) 2 (15)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.9988 (ns); p<sub>Control vs SERCA2</sub> =0.9813 (ns); p<sub>rab10 KD vs SERCA2</sub> =0.9655 (ns);</td></tr><tr><td align="left" valign="bottom">8 suppl 3E</td><td align="left" valign="bottom">DCV fused fraction</td><td align="left" valign="top">Control Rab10 KD SERCA2</td><td align="left" valign="top">2 (10) 2 (13) 2 (15)</td><td align="left" valign="top">ANOVA model comparison for nested linear models</td><td align="left" valign="top">p<sub>Control vs Rab10 KD</sub>=0.0003 (***); p<sub>Control vs SERCA2</sub> =0.0001 (****); p<sub>rab10 KD vs SERCA2</sub> =0.9711 (ns);</td></tr></tbody></table></table-wrap></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Visualization, Methodology</p></fn><fn fn-type="con" id="con3"><p>Visualization, Methodology</p></fn><fn fn-type="con" id="con4"><p>Visualization, Methodology</p></fn><fn fn-type="con" id="con5"><p>Methodology</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animals' experiments were approved by institutional and Dutch Animal Ethical Committee regulations (DEC-FGA 11-03).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-94930-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files; source data files have been provided for Figures 1, 5 and 8.</p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by a European Research Council (ERC) Advanced grant (322966) of the European Union (to MV), COSYN (Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders, Horizon 2020 Program of the European Union under RIA grant agreement 667301, to MV) and the JPND Neuron Cofund ERA-Net SNAREopathy (to RFT). We thank Rien Dekker for the electron microscopy data, Robbert Zalm and Ingrid Saarloos for cloning and producing viral particles, Joke Wortel for the animal breeding, Lisa Laan and Desiree Schut for glia and primary neuron culture assistance, Jurjen Broeke for technical support, and members of the DCV team for discussions and input. The authors declare no competing interests. Correspondence should be addressed to Matthijs Verhage at matthijs@cncr.vu.nl.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agola</surname><given-names>JO</given-names></name><name><surname>Jim</surname><given-names>PA</given-names></name><name><surname>Ward</surname><given-names>HH</given-names></name><name><surname>Basuray</surname><given-names>S</given-names></name><name><surname>Wandinger-Ness</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities</article-title><source>Clinical Genetics</source><volume>80</volume><fpage>305</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01724.x</pub-id><pub-id pub-id-type="pmid">21651512</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ailion</surname><given-names>M</given-names></name><name><surname>Hannemann</surname><given-names>M</given-names></name><name><surname>Dalton</surname><given-names>S</given-names></name><name><surname>Pappas</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Hegermann</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Han</surname><given-names>HF</given-names></name><name><surname>Gu</surname><given-names>M</given-names></name><name><surname>Goulding</surname><given-names>MQ</given-names></name><name><surname>Sasidharan</surname><given-names>N</given-names></name><name><surname>Schuske</surname><given-names>K</given-names></name><name><surname>Hullett</surname><given-names>P</given-names></name><name><surname>Eimer</surname><given-names>S</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Two Rab2 interactors regulate dense-core vesicle maturation</article-title><source>Neuron</source><volume>82</volume><fpage>167</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.02.017</pub-id><pub-id pub-id-type="pmid">24698274</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ananieva</surname><given-names>EA</given-names></name><name><surname>Powell</surname><given-names>JD</given-names></name><name><surname>Hutson</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Leucine metabolism in T cell activation: mTOR signaling and beyond</article-title><source>Advances in Nutrition</source><volume>7</volume><fpage>798S</fpage><lpage>805S</lpage><pub-id pub-id-type="doi">10.3945/an.115.011221</pub-id><pub-id pub-id-type="pmid">27422517</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>S</given-names></name><name><surname>Saarloos</surname><given-names>I</given-names></name><name><surname>Kooistra</surname><given-names>R</given-names></name><name><surname>van de Bospoort</surname><given-names>R</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SNAP-25 gene family members differentially support secretory vesicle fusion</article-title><source>Journal of Cell Science</source><volume>130</volume><fpage>1877</fpage><lpage>1889</lpage><pub-id pub-id-type="doi">10.1242/jcs.201889</pub-id><pub-id pub-id-type="pmid">28404788</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arruda</surname><given-names>AP</given-names></name><name><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes</article-title><source>Cell Metabolism</source><volume>22</volume><fpage>381</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.06.010</pub-id><pub-id pub-id-type="pmid">26190652</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azouz</surname><given-names>NP</given-names></name><name><surname>Zur</surname><given-names>N</given-names></name><name><surname>Efergan</surname><given-names>A</given-names></name><name><surname>Ohbayashi</surname><given-names>N</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Amihai</surname><given-names>D</given-names></name><name><surname>Hammel</surname><given-names>I</given-names></name><name><surname>Rothenberg</surname><given-names>ME</given-names></name><name><surname>Sagi-Eisenberg</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Rab5 Is a novel regulator of mast cell secretory granules: impact on size, cargo, and exocytosis</article-title><source>The Journal of Immunology</source><volume>192</volume><fpage>4043</fpage><lpage>4053</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1302196</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balkowiec</surname><given-names>A</given-names></name><name><surname>Katz</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>10399</fpage><lpage>10407</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-23-10399.2002</pub-id><pub-id pub-id-type="pmid">12451139</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Barde</surname><given-names>S</given-names></name><name><surname>Aguila</surname><given-names>J</given-names></name><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Solarz</surname><given-names>A</given-names></name><name><surname>Mei</surname><given-names>I</given-names></name><name><surname>Prud’homme</surname><given-names>J</given-names></name><name><surname>Palkovits</surname><given-names>M</given-names></name><name><surname>Turecki</surname><given-names>G</given-names></name><name><surname>Mulder</surname><given-names>J</given-names></name><name><surname>Uhlén</surname><given-names>M</given-names></name><name><surname>Nagy</surname><given-names>C</given-names></name><name><surname>Mechawar</surname><given-names>N</given-names></name><name><surname>Hedlund</surname><given-names>E</given-names></name><name><surname>Hökfelt</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Expression of substance P, NPY and their receptors is altered in major depression</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.12.14.516867</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Neuropeptides and obesity</article-title><source>Nutrition</source><volume>16</volume><fpage>916</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1016/s0899-9007(00)00410-x</pub-id><pub-id pub-id-type="pmid">11054597</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindea</surname><given-names>G</given-names></name><name><surname>Mlecnik</surname><given-names>B</given-names></name><name><surname>Hackl</surname><given-names>H</given-names></name><name><surname>Charoentong</surname><given-names>P</given-names></name><name><surname>Tosolini</surname><given-names>M</given-names></name><name><surname>Kirilovsky</surname><given-names>A</given-names></name><name><surname>Fridman</surname><given-names>WH</given-names></name><name><surname>Pagès</surname><given-names>F</given-names></name><name><surname>Trajanoski</surname><given-names>Z</given-names></name><name><surname>Galon</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1091</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp101</pub-id><pub-id pub-id-type="pmid">19237447</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britzolaki</surname><given-names>A</given-names></name><name><surname>Saurine</surname><given-names>J</given-names></name><name><surname>Flaherty</surname><given-names>E</given-names></name><name><surname>Thelen</surname><given-names>C</given-names></name><name><surname>Pitychoutis</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The SERCA2: a gatekeeper of neuronal calcium homeostasis in the brain</article-title><source>Cellular and Molecular Neurobiology</source><volume>38</volume><fpage>981</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1007/s10571-018-0583-8</pub-id><pub-id pub-id-type="pmid">29663107</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cajigas</surname><given-names>IJ</given-names></name><name><surname>Will</surname><given-names>T</given-names></name><name><surname>Schuman</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Protein homeostasis and synaptic plasticity</article-title><source>The EMBO Journal</source><volume>29</volume><fpage>2746</fpage><lpage>2752</lpage><pub-id pub-id-type="doi">10.1038/emboj.2010.173</pub-id><pub-id pub-id-type="pmid">20717144</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cawley</surname><given-names>NX</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Loh</surname><given-names>YP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>60 YEARS OF POMC: Biosynthesis, trafficking, and secretion OF pro-opiomelanocortin-derived peptides</article-title><source>Journal of Molecular Endocrinology</source><volume>56</volume><fpage>T77</fpage><lpage>T97</lpage><pub-id pub-id-type="doi">10.1530/JME-15-0323</pub-id><pub-id pub-id-type="pmid">26880796</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CCH</given-names></name><name><surname>Schweinsberg</surname><given-names>PJ</given-names></name><name><surname>Vashist</surname><given-names>S</given-names></name><name><surname>Mareiniss</surname><given-names>DP</given-names></name><name><surname>Lambie</surname><given-names>EJ</given-names></name><name><surname>Grant</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>RAB-10 is required for endocytic recycling in the <italic>Caenorhabditis elegans</italic> intestine</article-title><source>Molecular Biology of the Cell</source><volume>17</volume><fpage>1286</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.1091/mbc.e05-08-0787</pub-id><pub-id pub-id-type="pmid">16394106</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>KW</given-names></name><name><surname>Lahad</surname><given-names>JP</given-names></name><name><surname>Gray</surname><given-names>JW</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Emerging role of RAB GTPases in cancer and human disease</article-title><source>Cancer Research</source><volume>65</volume><fpage>2516</fpage><lpage>2519</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-0573</pub-id><pub-id pub-id-type="pmid">15805241</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Juan-Sanz</surname><given-names>J</given-names></name><name><surname>Holt</surname><given-names>GT</given-names></name><name><surname>Schreiter</surname><given-names>ER</given-names></name><name><surname>de Juan</surname><given-names>F</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Axonal endoplasmic reticulum Ca<sup>2+</sup> content controls release probability in CNS nerve terminals</article-title><source>Neuron</source><volume>93</volume><fpage>867</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.01.010</pub-id><pub-id pub-id-type="pmid">28162809</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>Moradi</surname><given-names>M</given-names></name><name><surname>Reinhard</surname><given-names>S</given-names></name><name><surname>Ji</surname><given-names>C</given-names></name><name><surname>Jablonka</surname><given-names>S</given-names></name><name><surname>Hennlein</surname><given-names>L</given-names></name><name><surname>Lüningschrör</surname><given-names>P</given-names></name><name><surname>Doose</surname><given-names>S</given-names></name><name><surname>Sauer</surname><given-names>M</given-names></name><name><surname>Sendtner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Dynamic remodeling of ribosomes and endoplasmic reticulum in axon terminals of motoneurons</article-title><source>Journal of Cell Science</source><volume>134</volume><elocation-id>jcs258785</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.258785</pub-id><pub-id pub-id-type="pmid">34668554</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>N</given-names></name><name><surname>van Weering</surname><given-names>JRT</given-names></name><name><surname>Borges</surname><given-names>R</given-names></name><name><surname>Toonen</surname><given-names>RFG</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dense-core vesicle biogenesis and exocytosis in neurons lacking chromogranins A and B</article-title><source>Journal of Neurochemistry</source><volume>144</volume><fpage>241</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1111/jnc.14263</pub-id><pub-id pub-id-type="pmid">29178418</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Droz</surname><given-names>B</given-names></name><name><surname>Rambourg</surname><given-names>A</given-names></name><name><surname>Koenig</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>The smooth endoplasmic reticulum: structure and role in the renewal of axonal membrane and synaptic vesicles by fast axonal transport</article-title><source>Brain Research</source><volume>93</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(75)90282-6</pub-id><pub-id pub-id-type="pmid">49212</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>SL</given-names></name><name><surname>Charlie</surname><given-names>NK</given-names></name><name><surname>Richmond</surname><given-names>JE</given-names></name><name><surname>Hegermann</surname><given-names>J</given-names></name><name><surname>Eimer</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Impaired dense core vesicle maturation in <italic>Caenorhabditis elegans</italic> mutants lacking Rab2</article-title><source>The Journal of Cell Biology</source><volume>186</volume><fpage>881</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1083/jcb.200902095</pub-id><pub-id pub-id-type="pmid">19797080</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emperador-Melero</surname><given-names>J</given-names></name><name><surname>Huson</surname><given-names>V</given-names></name><name><surname>van Weering</surname><given-names>J</given-names></name><name><surname>Bollmann</surname><given-names>C</given-names></name><name><surname>Fischer von Mollard</surname><given-names>G</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Vti1a/b regulate synaptic vesicle and dense core vesicle secretion via protein sorting at the Golgi</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3421</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05699-z</pub-id><pub-id pub-id-type="pmid">30143604</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Mechanism of action of caffeine on the sarcoplasmic reticulum of skeletal muscle</article-title><source>Proceedings of the Japan Academy</source><volume>51</volume><fpage>479</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.2183/pjab1945.51.479</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>English</surname><given-names>AR</given-names></name><name><surname>Voeltz</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Rab10 GTPase regulates ER dynamics and morphology</article-title><source>Nature Cell Biology</source><volume>15</volume><fpage>169</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1038/ncb2647</pub-id><pub-id pub-id-type="pmid">23263280</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farina</surname><given-names>M</given-names></name><name><surname>van de Bospoort</surname><given-names>R</given-names></name><name><surname>He</surname><given-names>E</given-names></name><name><surname>Persoon</surname><given-names>CM</given-names></name><name><surname>van Weering</surname><given-names>JRT</given-names></name><name><surname>Broeke</surname><given-names>JH</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CAPS-1 promotes fusion competence of stationary dense-core vesicles in presynaptic terminals of mammalian neurons</article-title><source>eLife</source><volume>4</volume><elocation-id>e05438</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.05438</pub-id><pub-id pub-id-type="pmid">25719439</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Hofmann</surname><given-names>O</given-names></name><name><surname>Dicker</surname><given-names>L</given-names></name><name><surname>Hide</surname><given-names>W</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Watkins</surname><given-names>SM</given-names></name><name><surname>Ivanov</surname><given-names>AR</given-names></name><name><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity</article-title><source>Nature</source><volume>473</volume><fpage>528</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1038/nature09968</pub-id><pub-id pub-id-type="pmid">21532591</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Kuba</surname><given-names>K</given-names></name><name><surname>Morita</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Calcium localization in the sympathetic ganglion of the bullfrog and effects of caffeine</article-title><source>Brain Research</source><volume>202</volume><fpage>21</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">6253025</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gärtner</surname><given-names>A</given-names></name><name><surname>Staiger</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Neurotrophin secretion from hippocampal neurons evoked by long-term-potentiation-inducing electrical stimulation patterns</article-title><source>PNAS</source><volume>99</volume><fpage>6386</fpage><lpage>6391</lpage><pub-id pub-id-type="doi">10.1073/pnas.092129699</pub-id><pub-id pub-id-type="pmid">11983920</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Lozano</surname><given-names>MA</given-names></name><name><surname>Koopmans</surname><given-names>F</given-names></name><name><surname>Paliukhovich</surname><given-names>I</given-names></name><name><surname>Smit</surname><given-names>AB</given-names></name><name><surname>Li</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A Fast and Economical Sample Preparation Protocol for Interaction Proteomics Analysis</article-title><source>Proteomics</source><volume>19</volume><elocation-id>e1900027</elocation-id><pub-id pub-id-type="doi">10.1002/pmic.201900027</pub-id><pub-id pub-id-type="pmid">30864274</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granseth</surname><given-names>B</given-names></name><name><surname>Odermatt</surname><given-names>B</given-names></name><name><surname>Royle</surname><given-names>SJ</given-names></name><name><surname>Lagnado</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Clathrin-mediated endocytosis is the dominant mechanism of vesicle retrieval at hippocampal synapses</article-title><source>Neuron</source><volume>51</volume><fpage>773</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.08.029</pub-id><pub-id pub-id-type="pmid">16982422</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannemann</surname><given-names>M</given-names></name><name><surname>Sasidharan</surname><given-names>N</given-names></name><name><surname>Hegermann</surname><given-names>J</given-names></name><name><surname>Kutscher</surname><given-names>LM</given-names></name><name><surname>Koenig</surname><given-names>S</given-names></name><name><surname>Eimer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>TBC-8, a Putative RAB-2 GAP, regulates dense core vesicle maturation in <italic>Caenorhabditis elegans</italic></article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1002722</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002722</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>M</given-names></name><name><surname>Heumann</surname><given-names>R</given-names></name><name><surname>Lessmann</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses</article-title><source>The EMBO Journal</source><volume>20</volume><fpage>5887</fpage><lpage>5897</lpage><pub-id pub-id-type="doi">10.1093/emboj/20.21.5887</pub-id><pub-id pub-id-type="pmid">11689429</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidelberger</surname><given-names>R</given-names></name><name><surname>Heinemann</surname><given-names>C</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name><name><surname>Matthews</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Calcium dependence of the rate of exocytosis in a synaptic terminal</article-title><source>Nature</source><volume>371</volume><fpage>513</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1038/371513a0</pub-id><pub-id pub-id-type="pmid">7935764</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>CE</given-names></name><name><surname>Martin</surname><given-names>KC</given-names></name><name><surname>Schuman</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Local translation in neurons: visualization and function</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>26</volume><fpage>557</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1038/s41594-019-0263-5</pub-id><pub-id pub-id-type="pmid">31270476</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homma</surname><given-names>Y</given-names></name><name><surname>Hiragi</surname><given-names>S</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Rab family of small GTPases: an updated view on their regulation and functions</article-title><source>The FEBS Journal</source><volume>288</volume><fpage>36</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1111/febs.15453</pub-id><pub-id pub-id-type="pmid">32542850</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobs</surname><given-names>MAH</given-names></name><name><surname>Dimitracopoulos</surname><given-names>A</given-names></name><name><surname>Franze</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>KymoButler, a deep learning software for automated kymograph analysis</article-title><source>eLife</source><volume>8</volume><elocation-id>e42288</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.42288</pub-id><pub-id pub-id-type="pmid">31405451</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karagas</surname><given-names>NE</given-names></name><name><surname>Venkatachalam</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Roles for the endoplasmic reticulum in regulation of neuronal calcium homeostasis</article-title><source>Cells</source><volume>8</volume><elocation-id>1232</elocation-id><pub-id pub-id-type="doi">10.3390/cells8101232</pub-id><pub-id pub-id-type="pmid">31658749</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiral</surname><given-names>FR</given-names></name><name><surname>Kohrs</surname><given-names>FE</given-names></name><name><surname>Jin</surname><given-names>EJ</given-names></name><name><surname>Hiesinger</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rab GTPases and membrane trafficking in neurodegeneration</article-title><source>Current Biology</source><volume>28</volume><fpage>R471</fpage><lpage>R486</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2018.02.010</pub-id><pub-id pub-id-type="pmid">29689231</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname><given-names>H</given-names></name><name><surname>Kaushik</surname><given-names>S</given-names></name><name><surname>Cuervo</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Protein homeostasis and aging: The importance of exquisite quality control</article-title><source>Ageing Research Reviews</source><volume>10</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.arr.2010.02.001</pub-id><pub-id pub-id-type="pmid">20152936</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koopmans</surname><given-names>F</given-names></name><name><surname>van Nierop</surname><given-names>P</given-names></name><name><surname>Andres-Alonso</surname><given-names>M</given-names></name><name><surname>Byrnes</surname><given-names>A</given-names></name><name><surname>Cijsouw</surname><given-names>T</given-names></name><name><surname>Coba</surname><given-names>MP</given-names></name><name><surname>Cornelisse</surname><given-names>LN</given-names></name><name><surname>Farrell</surname><given-names>RJ</given-names></name><name><surname>Goldschmidt</surname><given-names>HL</given-names></name><name><surname>Howrigan</surname><given-names>DP</given-names></name><name><surname>Hussain</surname><given-names>NK</given-names></name><name><surname>Imig</surname><given-names>C</given-names></name><name><surname>de Jong</surname><given-names>APH</given-names></name><name><surname>Jung</surname><given-names>H</given-names></name><name><surname>Kohansalnodehi</surname><given-names>M</given-names></name><name><surname>Kramarz</surname><given-names>B</given-names></name><name><surname>Lipstein</surname><given-names>N</given-names></name><name><surname>Lovering</surname><given-names>RC</given-names></name><name><surname>MacGillavry</surname><given-names>H</given-names></name><name><surname>Mariano</surname><given-names>V</given-names></name><name><surname>Mi</surname><given-names>H</given-names></name><name><surname>Ninov</surname><given-names>M</given-names></name><name><surname>Osumi-Sutherland</surname><given-names>D</given-names></name><name><surname>Pielot</surname><given-names>R</given-names></name><name><surname>Smalla</surname><given-names>K-H</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Tashman</surname><given-names>K</given-names></name><name><surname>Toonen</surname><given-names>RFG</given-names></name><name><surname>Verpelli</surname><given-names>C</given-names></name><name><surname>Reig-Viader</surname><given-names>R</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>van Weering</surname><given-names>J</given-names></name><name><surname>Achsel</surname><given-names>T</given-names></name><name><surname>Ashrafi</surname><given-names>G</given-names></name><name><surname>Asi</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>TC</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name><name><surname>Feuermann</surname><given-names>M</given-names></name><name><surname>Foulger</surname><given-names>RE</given-names></name><name><surname>Gaudet</surname><given-names>P</given-names></name><name><surname>Joglekar</surname><given-names>A</given-names></name><name><surname>Kanellopoulos</surname><given-names>A</given-names></name><name><surname>Malenka</surname><given-names>R</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name><name><surname>Pulido</surname><given-names>C</given-names></name><name><surname>de Juan-Sanz</surname><given-names>J</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Tilgner</surname><given-names>HU</given-names></name><name><surname>Bagni</surname><given-names>C</given-names></name><name><surname>Bayés</surname><given-names>À</given-names></name><name><surname>Biederer</surname><given-names>T</given-names></name><name><surname>Brose</surname><given-names>N</given-names></name><name><surname>Chua</surname><given-names>JJE</given-names></name><name><surname>Dieterich</surname><given-names>DC</given-names></name><name><surname>Gundelfinger</surname><given-names>ED</given-names></name><name><surname>Hoogenraad</surname><given-names>C</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Kaeser</surname><given-names>PS</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Kreutz</surname><given-names>MR</given-names></name><name><surname>McPherson</surname><given-names>PS</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>O’Connor</surname><given-names>V</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name><name><surname>Sala</surname><given-names>C</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Hyman</surname><given-names>SE</given-names></name><name><surname>Thomas</surname><given-names>PD</given-names></name><name><surname>Smit</surname><given-names>AB</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>SynGO: An evidence-based, expert-curated knowledge base for the synapse</article-title><source>Neuron</source><volume>103</volume><fpage>217</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.05.002</pub-id><pub-id pub-id-type="pmid">31171447</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laguesse</surname><given-names>S</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Protein translation and psychiatric disorders</article-title><source>The Neuroscientist</source><volume>26</volume><fpage>21</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1177/1073858419853236</pub-id><pub-id pub-id-type="pmid">31271100</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larance</surname><given-names>M</given-names></name><name><surname>Ramm</surname><given-names>G</given-names></name><name><surname>Stöckli</surname><given-names>J</given-names></name><name><surname>van Dam</surname><given-names>EM</given-names></name><name><surname>Winata</surname><given-names>S</given-names></name><name><surname>Wasinger</surname><given-names>V</given-names></name><name><surname>Simpson</surname><given-names>F</given-names></name><name><surname>Graham</surname><given-names>M</given-names></name><name><surname>Junutula</surname><given-names>JR</given-names></name><name><surname>Guilhaus</surname><given-names>M</given-names></name><name><surname>James</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking</article-title><source>The Journal of Biological Chemistry</source><volume>280</volume><fpage>37803</fpage><lpage>37813</lpage><pub-id pub-id-type="doi">10.1074/jbc.M503897200</pub-id><pub-id pub-id-type="pmid">16154996</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurent</surname><given-names>P</given-names></name><name><surname>Ch’ng</surname><given-names>Q</given-names></name><name><surname>Jospin</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Lorenzo</surname><given-names>R</given-names></name><name><surname>de Bono</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic dissection of neuropeptide cell biology at high and low activity in a defined sensory neuron</article-title><source>PNAS</source><volume>115</volume><fpage>E6890</fpage><lpage>E6899</lpage><pub-id pub-id-type="doi">10.1073/pnas.1714610115</pub-id><pub-id pub-id-type="pmid">29959203</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazo</surname><given-names>OM</given-names></name><name><surname>Schiavo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Rab10 regulates the sorting of internalised TrkB for retrograde axonal transport</article-title><source>eLife</source><volume>12</volume><elocation-id>e81532</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.81532</pub-id><pub-id pub-id-type="pmid">36897066</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>VK</given-names></name><name><surname>Lycas</surname><given-names>MD</given-names></name><name><surname>Schack</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>RC</given-names></name><name><surname>Gether</surname><given-names>U</given-names></name><name><surname>Kjaerulff</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rab2 drives axonal transport of dense core vesicles and lysosomal organelles</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.06.03.131672</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>P</given-names></name><name><surname>Sheng</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Gu</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Targeted disruption of Rab10 causes early embryonic lethality</article-title><source>Protein &amp; Cell</source><volume>6</volume><fpage>463</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1007/s13238-015-0150-8</pub-id><pub-id pub-id-type="pmid">25860786</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malva</surname><given-names>JO</given-names></name><name><surname>Xapelli</surname><given-names>S</given-names></name><name><surname>Baptista</surname><given-names>S</given-names></name><name><surname>Valero</surname><given-names>J</given-names></name><name><surname>Agasse</surname><given-names>F</given-names></name><name><surname>Ferreira</surname><given-names>R</given-names></name><name><surname>Silva</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Multifaces of neuropeptide Y in the brain--neuroprotection, neurogenesis and neuroinflammation</article-title><source>Neuropeptides</source><volume>46</volume><fpage>299</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/j.npep.2012.09.001</pub-id><pub-id pub-id-type="pmid">23116540</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mîinea</surname><given-names>CP</given-names></name><name><surname>Sano</surname><given-names>H</given-names></name><name><surname>Kane</surname><given-names>S</given-names></name><name><surname>Sano</surname><given-names>E</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Peränen</surname><given-names>J</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name><name><surname>Lienhard</surname><given-names>GE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain</article-title><source>The Biochemical Journal</source><volume>391</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1042/BJ20050887</pub-id><pub-id pub-id-type="pmid">15971998</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname><given-names>A</given-names></name><name><surname>van Woerden</surname><given-names>GM</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CaMKII controls neuromodulation via neuropeptide gene expression and axonal targeting of neuropeptide vesicles</article-title><source>PLOS Biology</source><volume>18</volume><elocation-id>e3000826</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000826</pub-id><pub-id pub-id-type="pmid">32776935</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname><given-names>A</given-names></name><name><surname>van Nifterick</surname><given-names>A</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Dynamin controls neuropeptide secretion by organizing dense-core vesicle fusion sites</article-title><source>Science Advances</source><volume>7</volume><elocation-id>eabf0659</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abf0659</pub-id><pub-id pub-id-type="pmid">34020952</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moya-Alvarado</surname><given-names>G</given-names></name><name><surname>Tiburcio-Felix</surname><given-names>R</given-names></name><name><surname>Ibáñez</surname><given-names>MR</given-names></name><name><surname>Aguirre-Soto</surname><given-names>AA</given-names></name><name><surname>Guerra</surname><given-names>MV</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Mobley</surname><given-names>WC</given-names></name><name><surname>Perlson</surname><given-names>E</given-names></name><name><surname>Bronfman</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>BDNF/TrkB signaling endosomes in axons coordinate CREB/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons</article-title><source>eLife</source><volume>12</volume><elocation-id>e77455</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.77455</pub-id><pub-id pub-id-type="pmid">36826992</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naldini</surname><given-names>L</given-names></name><name><surname>Blömer</surname><given-names>U</given-names></name><name><surname>Gallay</surname><given-names>P</given-names></name><name><surname>Ory</surname><given-names>D</given-names></name><name><surname>Mulligan</surname><given-names>R</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Verma</surname><given-names>IM</given-names></name><name><surname>Trono</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector</article-title><source>Science</source><volume>272</volume><fpage>263</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1126/science.272.5259.263</pub-id><pub-id pub-id-type="pmid">8602510</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nassal</surname><given-names>JP</given-names></name><name><surname>Murphy</surname><given-names>FH</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Differential axonal trafficking of Neuropeptide Y-, LAMP1-, and RAB7-tagged organelles in vivo</article-title><source>eLife</source><volume>11</volume><elocation-id>e81721</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.81721</pub-id><pub-id pub-id-type="pmid">36459486</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>JC</given-names></name><name><surname>Witkovsky</surname><given-names>P</given-names></name><name><surname>Avshalumov</surname><given-names>MV</given-names></name><name><surname>Rice</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>6568</fpage><lpage>6579</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0181-09.2009</pub-id><pub-id pub-id-type="pmid">19458227</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Periasamy</surname><given-names>M</given-names></name><name><surname>Kalyanasundaram</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>SERCA pump isoforms: their role in calcium transport and disease</article-title><source>Muscle &amp; Nerve</source><volume>35</volume><fpage>430</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1002/mus.20745</pub-id><pub-id pub-id-type="pmid">17286271</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persoon</surname><given-names>CM</given-names></name><name><surname>Moro</surname><given-names>A</given-names></name><name><surname>Nassal</surname><given-names>JP</given-names></name><name><surname>Farina</surname><given-names>M</given-names></name><name><surname>Broeke</surname><given-names>JH</given-names></name><name><surname>Arora</surname><given-names>S</given-names></name><name><surname>Dominguez</surname><given-names>N</given-names></name><name><surname>van Weering</surname><given-names>JR</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pool size estimations for dense-core vesicles in mammalian CNS neurons [WWW Document]</article-title><source>The EMBO Journal</source><volume>37</volume><elocation-id>e99672</elocation-id><pub-id pub-id-type="doi">10.15252/embj.201899672</pub-id><pub-id pub-id-type="pmid">30185408</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persoon</surname><given-names>CM</given-names></name><name><surname>Hoogstraaten</surname><given-names>RI</given-names></name><name><surname>Nassal</surname><given-names>JP</given-names></name><name><surname>van Weering</surname><given-names>JRT</given-names></name><name><surname>Kaeser</surname><given-names>PS</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The RAB3-RIM pathway is essential for the release of neuromodulators</article-title><source>Neuron</source><volume>104</volume><fpage>1065</fpage><lpage>1080</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.09.015</pub-id><pub-id pub-id-type="pmid">31679900</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poo</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Neurotrophins as synaptic modulators</article-title><source>Nature Reviews. Neuroscience</source><volume>2</volume><fpage>24</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/35049004</pub-id><pub-id pub-id-type="pmid">11253356</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sah</surname><given-names>R</given-names></name><name><surname>Geracioti</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neuropeptide Y and posttraumatic stress disorder</article-title><source>Molecular Psychiatry</source><volume>18</volume><fpage>646</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1038/mp.2012.101</pub-id><pub-id pub-id-type="pmid">22801411</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salio</surname><given-names>C</given-names></name><name><surname>Lossi</surname><given-names>L</given-names></name><name><surname>Ferrini</surname><given-names>F</given-names></name><name><surname>Merighi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Neuropeptides as synaptic transmitters</article-title><source>Cell and Tissue Research</source><volume>326</volume><fpage>583</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1007/s00441-006-0268-3</pub-id><pub-id pub-id-type="pmid">16847638</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>H</given-names></name><name><surname>Eguez</surname><given-names>L</given-names></name><name><surname>Teruel</surname><given-names>MN</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Chuang</surname><given-names>TD</given-names></name><name><surname>Chavez</surname><given-names>JA</given-names></name><name><surname>Lienhard</surname><given-names>GE</given-names></name><name><surname>McGraw</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane</article-title><source>Cell Metabolism</source><volume>5</volume><fpage>293</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2007.03.001</pub-id><pub-id pub-id-type="pmid">17403373</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasidharan</surname><given-names>N</given-names></name><name><surname>Sumakovic</surname><given-names>M</given-names></name><name><surname>Hannemann</surname><given-names>M</given-names></name><name><surname>Hegermann</surname><given-names>J</given-names></name><name><surname>Liewald</surname><given-names>JF</given-names></name><name><surname>Olendrowitz</surname><given-names>C</given-names></name><name><surname>Koenig</surname><given-names>S</given-names></name><name><surname>Grant</surname><given-names>BD</given-names></name><name><surname>Rizzoli</surname><given-names>SO</given-names></name><name><surname>Gottschalk</surname><given-names>A</given-names></name><name><surname>Eimer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>RAB-5 and RAB-10 cooperate to regulate neuropeptide release in <italic>Caenorhabditis elegans</italic></article-title><source>PNAS</source><volume>109</volume><fpage>18944</fpage><lpage>18949</lpage><pub-id pub-id-type="doi">10.1073/pnas.1203306109</pub-id><pub-id pub-id-type="pmid">23100538</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>EK</given-names></name><name><surname>Clavarino</surname><given-names>G</given-names></name><name><surname>Ceppi</surname><given-names>M</given-names></name><name><surname>Pierre</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>SUnSET, a nonradioactive method to monitor protein synthesis</article-title><source>Nature Methods</source><volume>6</volume><fpage>275</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1314</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>SK</given-names></name><name><surname>Hjorth</surname><given-names>JJJ</given-names></name><name><surname>Joemai</surname><given-names>RMS</given-names></name><name><surname>Wijntjes</surname><given-names>R</given-names></name><name><surname>Eijgenraam</surname><given-names>S</given-names></name><name><surname>de Bruijn</surname><given-names>P</given-names></name><name><surname>Georgiou</surname><given-names>C</given-names></name><name><surname>de Jong</surname><given-names>APH</given-names></name><name><surname>van Ooyen</surname><given-names>A</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Cornelisse</surname><given-names>LN</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name><name><surname>Veldkamp</surname><given-names>WJH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Automated analysis of neuronal morphology, synapse number and synaptic recruitment</article-title><source>Journal of Neuroscience Methods</source><volume>195</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2010.12.011</pub-id><pub-id pub-id-type="pmid">21167201</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakiryanova</surname><given-names>D</given-names></name><name><surname>Klose</surname><given-names>MK</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>T</given-names></name><name><surname>Deitcher</surname><given-names>DL</given-names></name><name><surname>Atwood</surname><given-names>HL</given-names></name><name><surname>Hewes</surname><given-names>RS</given-names></name><name><surname>Levitan</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Presynaptic ryanodine receptor-activated calmodulin kinase II increases vesicle mobility and potentiates neuropeptide release</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>7799</fpage><lpage>7806</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1879-07.2007</pub-id><pub-id pub-id-type="pmid">17634373</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>YT</given-names></name><name><surname>Hsueh</surname><given-names>YP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>VCP and ATL1 regulate endoplasmic reticulum and protein synthesis for dendritic spine formation</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11020</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11020</pub-id><pub-id pub-id-type="pmid">26984393</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Klingauf</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Two synaptobrevin molecules are sufficient for vesicle fusion in central nervous system synapses</article-title><source>PNAS</source><volume>108</volume><fpage>14318</fpage><lpage>14323</lpage><pub-id pub-id-type="doi">10.1073/pnas.1101818108</pub-id><pub-id pub-id-type="pmid">21844343</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumakovic</surname><given-names>M</given-names></name><name><surname>Hegermann</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Husson</surname><given-names>SJ</given-names></name><name><surname>Schwarze</surname><given-names>K</given-names></name><name><surname>Olendrowitz</surname><given-names>C</given-names></name><name><surname>Schoofs</surname><given-names>L</given-names></name><name><surname>Richmond</surname><given-names>J</given-names></name><name><surname>Eimer</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>UNC-108/RAB-2 and its effector RIC-19 are involved in dense core vesicle maturation in <italic>Caenorhabditis elegans</italic></article-title><source>The Journal of Cell Biology</source><volume>186</volume><fpage>897</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1083/jcb.200902096</pub-id><pub-id pub-id-type="pmid">19797081</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takamori</surname><given-names>S</given-names></name><name><surname>Holt</surname><given-names>M</given-names></name><name><surname>Stenius</surname><given-names>K</given-names></name><name><surname>Lemke</surname><given-names>EA</given-names></name><name><surname>Grønborg</surname><given-names>M</given-names></name><name><surname>Riedel</surname><given-names>D</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Schenck</surname><given-names>S</given-names></name><name><surname>Brügger</surname><given-names>B</given-names></name><name><surname>Ringler</surname><given-names>P</given-names></name><name><surname>Müller</surname><given-names>SA</given-names></name><name><surname>Rammner</surname><given-names>B</given-names></name><name><surname>Gräter</surname><given-names>F</given-names></name><name><surname>Hub</surname><given-names>JS</given-names></name><name><surname>De Groot</surname><given-names>BL</given-names></name><name><surname>Mieskes</surname><given-names>G</given-names></name><name><surname>Moriyama</surname><given-names>Y</given-names></name><name><surname>Klingauf</surname><given-names>J</given-names></name><name><surname>Grubmüller</surname><given-names>H</given-names></name><name><surname>Heuser</surname><given-names>J</given-names></name><name><surname>Wieland</surname><given-names>F</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Molecular anatomy of a trafficking organelle</article-title><source>Cell</source><volume>127</volume><fpage>831</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.10.030</pub-id><pub-id pub-id-type="pmid">17110340</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taoufiq</surname><given-names>Z</given-names></name><name><surname>Ninov</surname><given-names>M</given-names></name><name><surname>Villar-Briones</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Roy</surname><given-names>MC</given-names></name><name><surname>Beauchain</surname><given-names>F</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Takamori</surname><given-names>S</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hidden proteome of synaptic vesicles in the mammalian brain</article-title><source>PNAS</source><volume>117</volume><fpage>33586</fpage><lpage>33596</lpage><pub-id pub-id-type="doi">10.1073/pnas.2011870117</pub-id><pub-id pub-id-type="pmid">33376223</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>CA</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Howell</surname><given-names>AS</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>RAB-10 regulates dendritic branching by balancing dendritic transport</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005695</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005695</pub-id><pub-id pub-id-type="pmid">26633194</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>JG</given-names></name><name><surname>Lee</surname><given-names>AK</given-names></name><name><surname>Almers</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A low affinity Ca2+ receptor controls the final steps in peptide secretion from pituitary melanotrophs</article-title><source>Neuron</source><volume>11</volume><fpage>93</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(93)90274-u</pub-id><pub-id pub-id-type="pmid">8393324</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tooze</surname><given-names>SA</given-names></name><name><surname>Martens</surname><given-names>GJM</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Secretory granule biogenesis: rafting to the SNARE</article-title><source>Trends in Cell Biology</source><volume>11</volume><fpage>116</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/s0962-8924(00)01907-3</pub-id><pub-id pub-id-type="pmid">11306272</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valadas</surname><given-names>JS</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>Vandekerkhove</surname><given-names>D</given-names></name><name><surname>Miskiewicz</surname><given-names>K</given-names></name><name><surname>Deaulmerie</surname><given-names>L</given-names></name><name><surname>Raitano</surname><given-names>S</given-names></name><name><surname>Seibler</surname><given-names>P</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Verstreken</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>ER lipid defects in neuropeptidergic neurons impair sleep patterns in Parkinson’s disease</article-title><source>Neuron</source><volume>98</volume><fpage>1155</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.05.022</pub-id><pub-id pub-id-type="pmid">29887339</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Bospoort</surname><given-names>R</given-names></name><name><surname>Farina</surname><given-names>M</given-names></name><name><surname>Schmitz</surname><given-names>SK</given-names></name><name><surname>de Jong</surname><given-names>A</given-names></name><name><surname>de Wit</surname><given-names>H</given-names></name><name><surname>Verhage</surname><given-names>M</given-names></name><name><surname>Toonen</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Munc13 controls the location and efficiency of dense-core vesicle release in neurons</article-title><source>The Journal of Cell Biology</source><volume>199</volume><fpage>883</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1083/jcb.201208024</pub-id><pub-id pub-id-type="pmid">23229896</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>XH</given-names></name><name><surname>Deng</surname><given-names>CY</given-names></name><name><surname>Wu</surname><given-names>KY</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>XQ</given-names></name><name><surname>He</surname><given-names>M</given-names></name><name><surname>Luo</surname><given-names>ZG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Lgl1 activation of rab10 promotes axonal membrane trafficking underlying neuronal polarization</article-title><source>Developmental Cell</source><volume>21</volume><fpage>431</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.07.007</pub-id><pub-id pub-id-type="pmid">21856246</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Whiteus</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>CS</given-names></name><name><surname>Hayworth</surname><given-names>KJ</given-names></name><name><surname>Weinberg</surname><given-names>RJ</given-names></name><name><surname>Hess</surname><given-names>HF</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Contacts between the endoplasmic reticulum and other membranes in neurons</article-title><source>PNAS</source><volume>114</volume><fpage>E4859</fpage><lpage>E4867</lpage><pub-id pub-id-type="doi">10.1073/pnas.1701078114</pub-id><pub-id pub-id-type="pmid">28559323</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>XH</given-names></name><name><surname>Deng</surname><given-names>CY</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>M</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>ZS</given-names></name><name><surname>Blackshear</surname><given-names>PJ</given-names></name><name><surname>Luo</surname><given-names>ZG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MARCKS regulates membrane targeting of Rab10 vesicles to promote axon development</article-title><source>Cell Research</source><volume>24</volume><fpage>576</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1038/cr.2014.33</pub-id><pub-id pub-id-type="pmid">24662485</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Van Remmen</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The SarcoEndoplasmic Reticulum Calcium ATPase (SERCA) pump: a potential target for intervention in aging and skeletal muscle pathologies</article-title><source>Skeletal Muscle</source><volume>11</volume><elocation-id>2807</elocation-id><pub-id pub-id-type="doi">10.1186/s13395-021-00280-7</pub-id><pub-id pub-id-type="pmid">34772465</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.94930.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Verstreken</surname><given-names>Patrik</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>KU Leuven</institution><country>Belgium</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Fundamental</kwd></kwd-group></front-stub><body><p>In this revised manuscript, Dong et al. investigate the role of the small Ras-like GTPase Rab10 in the exocytosis of DCVs in mouse hippocampal neurons, showing that Rab10 depletion hinders DCV exocytosis independently of its effects on neurite outgrowth. Upon revising their work, these findings provide <bold>compelling</bold> evidence that Rab10 depletion leads to altered ER morphology, impaired ER-based calcium buffering, and decreased ribosomal protein expression, which collectively contributes to defective DCV secretion. The study comes to the <bold>fundamental</bold> conclusion that Rab10 is critical for DCV release by ensuring ER calcium homeostasis.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.94930.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Dong et al here have studied the impact of the small Ras-like GTPase Rab10 on the exocytosis of dense core vesicles (DVC), which are important mediators of neuropeptide signaling in brain. They use optical imaging to show that lentiviral depletion of Rab10 in mouse hippocampal neurons in culture independent of the established defects in neurite outgrowth hamper DCV exocytosis. They further demonstrate that such defects are paralleled by changes in ER morphology and defective ER-based calcium buffering as well as reduced ribosomal protein expression in Rab10-depleted neurons. Re-expression of Rab10 or supplementation of exogenous L-leucine to restore defective neuronal protein synthesis rescues impaired DCV secretion. Based on these results they propose that Rab10 regulates DCV release by maintaining ER calcium homeostasis and neuronal protein synthesis.</p><p>Strengths:</p><p>This work provides interesting and potentially important new insights into the connection between ER function and the regulated secretion of neuropeptides via DCVs. The authors combine advanced optical imaging with light and electron microscopy, biochemistry and proteomics approaches to thoroughly assess the effects of Rab10 knockdown at the cellular level in primary neurons. The proteomic dataset provided may be valuable in facilitating future studies regarding Rab10 function. This work will thus be of interest to neuroscientists and cell biologists.</p><p>Weaknesses:</p><p>Whether and how the phenotypes of Rab10 reported in this study are linked remains an open question. Likewise, a possible role of Rab10 in exocytosis cannot be excluded at this stage.</p><p>Comments on revisions:</p><p>My previous questions and concerns have been satisfactorily addressed by the authors.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.94930.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this paper, the authors assess the function of Rab10 in dense core vesicle (DCV) exocytosis using RNAi and cultured neurons. The author provides evidence that their knockdown (KD) is effective and provides evidence that DCV is compromised. They also perform proteomic analysis to identify potential pathway that are affected upon KD of Rab10 that may be involved in DCV release. Upon focusing on ER morphology and protein synthesis, the authors conclude that defects in protein synthesis and ER Ca2+ homeostasis contributes to the DVC release defect upon Rab10 KD.</p><p>Strengths:</p><p>The data related to Rab10's role in DCV release seems to be strong and carried out with rigor. While the paper lacks in vivo evidence that this gene is indeed involved in DCV in a living mammalian organism, I feel the cellular studies have value. The identification of ER defect in Rab10 manipulation is not truly novel but it is a good conformation of studies performed in other systems. The finding that DCV release defect and protein synthesis defect seen upon Rab10 KD can be significantly suppressed by Leucine supplementation is also a strength of this work.</p><p>Weaknesses:</p><p>The weaknesses mentioned in my previous comments have been addressed through the revision process.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.94930.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>In this study, Dong and colleagues set to dissect the role of Rab10 small GTPase on the intracellular trafficking and exocytosis of dense core vesicles (DCVs). While the authors have already shown that Rab3 plays a central role in the exocytosis of DVC in mammalian neurons, the roles of several other Rab-members have been identified genetically, but their precise mechanism of action in mammalian neurons remains unclear. In this study, the authors use a carefully designed and thoroughly executed series of experiments, including live-cell imaging, functional calcium-imaging, proteomics, and electron microscopy, to identify that DCV secretion upon Rab10 depletion in adult neurons is primarily a result of dysregulated protein synthesis and, to a lesser extent, disrupted intracellular calcium buffering. Given that the full deletion of Rab10 has deleterious effect on neurons and that Rab10 has a major role in axonal development, the authors cautiously employed the knock-down strategy from 7 DIV, to focus on the functional impact of Rab10 in mature neurons. The experiments in this study were meticulously conducted, incorporating essential controls and thoughtful considerations, ensuring rigorous and comprehensive results that fully support the conclusions.</p><p>Comments on revisions:</p><p>The authors have addressed all the comments and suggestions raised by reviewers, making this an excellent and timely study.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.94930.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dong</surname><given-names>Jian</given-names></name><role specific-use="author">Author</role><aff><institution>VU Amsterdam</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Mian</given-names></name><role specific-use="author">Author</role><aff><institution>VU Amsterdam</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib><contrib contrib-type="author"><name><surname>van Weering</surname><given-names>Jan RT</given-names></name><role specific-use="author">Author</role><aff><institution>Amsterdam UMC Location VUmc</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Ka Wan</given-names></name><role specific-use="author">Author</role><aff><institution>Vrije Universiteit</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib><contrib contrib-type="author"><name><surname>Smit</surname><given-names>August B</given-names></name><role specific-use="author">Author</role><aff><institution>Vrije Universiteit</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib><contrib contrib-type="author"><name><surname>Toonen</surname><given-names>Ruud F</given-names></name><role specific-use="author">Author</role><aff><institution>VU University Amsterdam</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib><contrib contrib-type="author"><name><surname>Verhage</surname><given-names>Matthijs</given-names></name><role specific-use="author">Author</role><aff><institution>VU Amsterdam</institution><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>Dong et al here have studied the impact of the small Ras-like GTPase Rab10 on the exocytosis of dense core vesicles (DVC), which are important mediators of neuropeptide signaling in the brain. They use optical imaging to show that lentiviral depletion of Rab10 in mouse hippocampal neurons in culture independent of the established defects in neurite outgrowth hamper DCV exocytosis. They further demonstrate that such defects are paralleled by changes in ER morphology and defective ER-based calcium buffering as well as reduced ribosomal protein expression in Rab10-depleted neurons. Re-expression of Rab10 or supplementation of exogenous L-leucine to restore defective neuronal protein synthesis rescues impaired DCV secretion. Based on these results they propose that Rab10 regulates DCV release by maintaining ER calcium homeostasis and neuronal protein synthesis.</p><p>Strengths:</p><p>This work provides interesting and potentially important new insights into the connection between ER function and the regulated secretion of neuropeptides via DCVs. The authors combine advanced optical imaging with light and electron microscopy, biochemistry, and proteomics approaches to thoroughly assess the effects of Rab10 knockdown at the cellular level in primary neurons. The proteomic dataset provided may be valuable in facilitating future studies regarding Rab10 function. This work will thus be of interest to neuroscientists and cell biologists.</p></disp-quote><p>We appreciate the positive evaluation of our manuscript.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>While the main conclusions of this study are comparably well supported by the data, I see three major weaknesses:</p><p>(1) For some of the data the statistical basis for analysis remains unclear. I.e. is the statistical assessment based on N = number of experiments or n = number of synapses, images, fields of view etc.? As the latter cannot be considered independent biological replicates, they should not form the basis of statistical testing.</p></disp-quote><p>This is an important point and we agree that multiple samples from the same biological replicate are not independent observations. We reanalyzed all nested data using a linear mixed model and indicated this in the Methods section and the relevant figure legends (Brunner et al., 2022). In brief, biological replicates (individual neuronal cultures) were used as a linear predictor. Outliers were identified and excluded using the ROUT method in GraphPad. A fixed linear regression model was then fitted to the data using the lm() function in R. A one-way anova (analysis of variance) was used to assess whether including the experimental group as a second linear predictor (formula = y ~ Group + Culture) statistically improved the fit of a model without group information (formula = y ~ 1 + Culture). Post-hoc analysis was performed using the emmeans() function with Tukey’s adjustment when more than two experimental groups were present. Importantly, our conclusions remain unchanged.</p><disp-quote content-type="editor-comment"><p>(2) As it stands the paper reports on three partially independent phenotypic observations, the causal interrelationship of which remains unclear. Based on prior studies (e.g. Mercan et al 2013 Mol Cell Biol; Graves et al JBC 1997) it is conceivable that defective ER-based calcium signaling and the observed reduction in protein synthesis are causally related. For example, ER calcium release is known to promote pS6K1 phosphorylation, a major upstream regulator of protein synthesis and ribosome biogenesis. Conversely, L-leucine supplementation is known to trigger calcium release from ER stores via IP3Rs. Given the reported impact of Rab10 on axonal transport of autophagosomes and, possibly, lysosomes via JIP3/4 or other mediators (see e.g. Cason and Holzbaur JCB 2023) and the fact that mTORC1, the alleged target of leucine supplementation, is located on lysosomes, which in turn form membrane contacts with the ER, it seems worth analyzing whether the various phenotypes observed are linked at the level of mTORC1 signaling.</p></disp-quote><p>This is great suggestion that could indeed further clarify the potential interplay between ER-based Ca2+ signaling and protein synthesis. To address this, we assessed the phosphorylation level of pS6K1 in control and Rab10 knockdown (KD) neurons with or without leucine treatment. These data are included in the new Figure 8—figure supplement 1 in the revised manuscript. Our results indicate that pS6K1 phosphorylation was not upregulated in Rab10 KD neurons, suggesting that the level of mTORC1 signaling is not different between wild-type or KD neurons. Furthermore, leucine treatment increased the pS6K1 phosphorylation level, as expected, but this effect was similar in both groups. Hence, we conclude that differences in mTORC1 signaling induced by Rab10 loss is not a major factor in the observed impairment in protein synthesis.<xref ref-type="fig" rid="sa4fig1">Author response image 1</xref></p><fig id="sa4fig1" position="float"><label>Author response image 1.</label><caption><title>Rab10 depletion does not upregulate mTORC1 pathway.</title><p>(A)Typical immunoblot showing pS6K1 levels in each condition. (B) Quantification of relative pS6K1 levels in each condition. All Data are plotted as mean± s.e.m. (C) Control, Control + Leu: N = 2, n = 2, Rab10 KD, Rab10 KD + Leu: N = 2, n = 4.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-sa4-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>(3) The claimed lack of effect of Rab10 depletion on SV exocytosis is solely based on very strong train stimulation with 200 Aps, a condition not very well suited to analyze defects in SV fusion. The conclusion that Rab10 loss does not impact SV fusion thus seems premature.</p></disp-quote><p>We agree that 200 APs stimulation might be too strong to detect specific effects on evoked synaptic vesicle release, although this stimulation pattern is an established pattern in hundreds of studies (Emperador-Melero et al., 2018; Granseth et al., 2006; Ivanova et al., 2021; Kwon and Chapman, 2011; Reshetniak et al., 2020). We have toned down our conclusions and clarified in the revised manuscript that Rab10 is dispensable for SV exocytosis evoked by intense stimulations. The corresponding statements in the text have been modified accordingly (p. 5, l. 98, 124) and in figure legend (p. 17, 490).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>In this paper, the authors assess the function of Rab10 in dense core vesicle (DCV) exocytosis using RNAi and cultured neurons. The author provides evidence that their knockdown (KD) is effective and provides evidence that DCV is compromised. They also perform proteomic analysis to identify potential pathways that are affected upon KD of Rab10 that may be involved in DCV release. Upon focusing on ER morphology and protein synthesis, the authors conclude that defects in protein synthesis and ER Ca2+ homeostasis contributes to the DVC release defect upon Rab10 KD. The authors claim that Rab10 is not involved in synaptic vesicle (SV) release and membrane homeostasis in mature neurons.</p><p>Strengths:</p><p>The data related to Rab10's role in DCV release seems to be strong and carried out with rigor. While the paper lacks in vivo evidence that this gene is indeed involved in DCV in a living mammalian organism, I feel the cellular studies have value. The identification of ER defect in Rab10 manipulation is not truly novel but it is a good conformation of studies performed in other systems. The finding that DCV release defect and protein synthesis defect seen upon Rab10 KD can be significantly suppressed by Leucine supplementation is also a strength of this work.</p></disp-quote><p>We appreciate the positive evaluation of our manuscript.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>The data showing Rab10 is NOT involved in SV exocytosis seems a bit weak to me. Since the proteomic analysis revealed so many proteins that are involved in SV exo/encodytosis to be affected upon Rab10, it is a bit strange that they didn't see an obvious defect. Perhaps this could have been because of the protocol that the authors used to trigger SV release (I am not an E-phys expert but perhaps this could have been a 'sledge-hammer' manipulation that may mask any subtle defects)? Perhaps the authors can claim that DCV is more sensitive to Rab10 KD than SV, but I am not sure whether the authors should make a strong claim about Rab10 not being important for SV exocytosis.</p></disp-quote><p>We agree that 200 APs stimulation might be too strong to see specific effects on evoked synaptic vesicle release, although this stimulation pattern is an established pattern in hundreds of studies. We have toned down our conclusions and clarified in the revised manuscript that Rab10 is dispensable for SV exocytosis evoked by intense stimulations. The corresponding statements in the text have been modified accordingly (p. 5, l. 98, 124) and in figure legend (p. 17, 490).</p><disp-quote content-type="editor-comment"><p>Also, the authors mention &quot;Rab10 does not regulate membrane homeostasis in mature neurons&quot; but I feel this is an overstatement. Since the authors only performed KD experiments, not knock-out (KO) experiments, I believe they should not make any conclusion about it not being required, especially since there is some level of Rab10 present in their cells. If they want to make these claims, I believe the authors will need to perform conditional KO experiments, which are not performed in this study.</p></disp-quote><p>This is a valid point. We have changed the statement to “membrane homeostasis in mature neurons was unaffected by Rab10 knockdown” (p. 13, l.376-377).</p><disp-quote content-type="editor-comment"><p>Finally, the authors show that protein synthesis and ER Ca2+ defects seem to contribute to the defect but they do not discuss the relationship between the two defects. If the authors treat the Rab10 KD cells with both ionomycin and Leucine, do they get a full rescue? Or is one defect upstream of the other (e.g. can they see rescue of ER morphology upon Leucine treatment)? While this is not critical for the conclusions of the paper, several additional experiments could be performed to clarify their model, especially considering there is no clear model that explains how Rab10, protein synthesis, ER homeostasis, and Ca2+ are related to DCV (but not SV) exocytosis.</p></disp-quote><p>This is an important point and a great suggestion. We have now tested the rescue effects of leucine treatment on ER morphology, as suggested. These data are included in the new Figure 8—figure supplement 2 in the revised manuscript. Our results indicate that the same dose of leucine that rescues DCV fusion and protein translation failed to rescue ER morphology. Hence, the defects in ER morphology appear to be independent of the impaired protein translation.</p><p>Author response image 2.</p><p>Leucine supplementation does not rescue ER morphological deficiency in Rab10 KD neurons. (A) Typical examples showing the KDEL signals in each condition. (B) Quantification of RTN4 intensity in MAP2-positive dendrites. (C) The ratio of neuritic to somatic RTN4 intensity (N/S).</p><p>All Data are plotted as mean ± s.e.m. (B, C) Control: N = 3, n = 10; Rab10 KD: N = 3, n = 11; Rab10 KD + Leu: N = 3; n = 11. A one-way ANOVA tested the significance of adding experimental group as a predictor. **** = p&lt;0.0001, ns = not significant.<xref ref-type="fig" rid="sa4fig2">Author response image 2</xref></p><fig id="sa4fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-94930-sa4-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public Review):</bold></p><p>In the submitted manuscript, Dong and colleagues set out to dissect the role of the Rab10 small GTPase on the intracellular trafficking and exocytosis of dense core vesicles (DCVs). While the authors have already shown that Rab3 plays a central role in the exocytosis of DVC in mammalian neurons, the roles of several other Rab-members have been identified genetically, but their precise mechanism of action in mammalian neurons remains unclear. In this study, the authors use a carefully designed and thoroughly executed series of experiments, including live-cell imaging, functional calcium-imaging, proteomics, and electron microscopy, to identify that DCV secretion upon Rab10 depletion in adult neurons is primarily a result of dysregulated protein synthesis and, to a lesser extent, disrupted intracellular calcium buffering. Given that the full deletion of Rab10 has a deleterious effect on neurons and that Rab10 has a major role in axonal development, the authors cautiously employed the knock-down strategy from 7 DIV, to focus on the functional impact of Rab10 in mature neurons. The experiments in this study were meticulously conducted, incorporating essential controls and thoughtful considerations, ensuring rigorous and comprehensive results.</p></disp-quote><p>We are grateful for the positive evaluation of our manuscript.</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>The work by Dong et al provides interesting and potentially important new insights into the connection between ER function and the regulated secretion of neuropeptides via DCVs. I suggest that the authors address the following points experimentally to increase the impact of this potentially important study.</p><p>Major points:</p><p>(1) As alluded to above, for some of the data the statistical basis for analysis remains unclear (examples are Figures 1C-F, J,K; Figure 2 1B-D,I-K; Figure 2 - Supplement 1D-F; Figure 2 - Supplement 2J,K, etc). I.e. is the statistical assessment based on N = number of experiments or n = number of synapses, images, fields of view etc.? As the latter cannot be considered independent biological replicates, they should not form the basis of statistical testing. The Ms misses also misses a dedicated paragraph on statistics in the methods section.</p></disp-quote><p>See reply to reviewer 1 above. We fully agree and solved this point.</p><disp-quote content-type="editor-comment"><p>(2) A main weakness of the paper is the missing connection between neuronal protein synthesis, and the observed structural and signaling defects at the level of the ER. I suggest that the authors analyze mTORC1 signaling in Rab10 depleted neurons and under rescue conditions (+Leu or re-expression of Rab10) as ribosome biogenesis is a major downstream target of mTORC1 and mTORC1 activity is related to lysosome position, which may be affected upon rab10 loss -either directly or via effects on the ER that forms tight contacts with lysosomes.</p></disp-quote><p>See reply to reviewer 1 above. We agreed and followed up experimentally.</p><disp-quote content-type="editor-comment"><p>(3) Related to the above: Does overexpression of SERCA2 restore normal DCV exocytosis in Rab10-depleted neurons? This would help to distinguish whether calcium storage and release at the level of the ER indeed contribute to the exocytosis defect.</p></disp-quote><p>This is an important point and a great suggestion. We have now tested the rescue effects of overexpression of SERCA2 on DCV fusion. These data are included in the new Figure 8—figure supplement 3 in the revised manuscript. SERCA2 OE failed to rescue the DCV fusion defects in Rab10 KD neurons.</p><p>Author response image 3.</p><p>Overexpression of SERCA2 does not rescue DCV fusion deficits in Rab10 KD neurons. (A) Typical examples showing the SERCA2 signals in each condition. (B) Cumulative plot of DCV fusion events per cell. (C) Summary graph of DCV fusion events per cell. (A) Total number of DCVs (total pool) per neuron, measured as the number of NPY-pHluorin puncta upon NH4Cl perfusion. (B) Fraction of NPY-pHluorin-labeled DCVs fusing during stimulation.</p><p>All Data are plotted as mean ± s.e.m. (C-E) Control: N = 2, n = 10; Rab10 KD: N = 2, n = 13; SERCA2 OE: N = 2; n = 15. A one-way ANOVA tested the significance of adding experimental group as a predictor. *** = p&lt;0.001, ** = p&lt;0.01, ns = not significant.</p><p><inline-formula><mml:math id="sa4m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left" rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:mtext> B - Control - Rab10 KD - SERCA2 OE </mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext> E </mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></inline-formula></p><disp-quote content-type="editor-comment"><p>(4) The claimed lack of effect of Rab10 depletion on SV exocytosis is solely based on very strong train stimulation with 200 Aps, a condition not very well suited to analyze defects in SV fusion. The conclusion that Rab10 loss does not impact SV fusion thus seems premature. The authors should conduct additional experiments under conditions of single or few Aps (e.g. 4 or 10 Aps) to really assess whether or not Rab10 depletion alters SV exocytosis at the level of pHluorin analysis in cultured neurons.</p></disp-quote><p>See reply to reviewer 2 above. Agreed to and made textual adjustments to solve this</p><disp-quote content-type="editor-comment"><p>(5) Related to the above: I am puzzled by the data shown in Figure 1H-J: From the pHluorin traces shown I would estimate a tau value of about 20-30 s (e.g. decay to 1/e = 37% of the peak value). The bar graph in Figure 1K claims 3-4 s, clearly clashing with the data shown. Were these experiments conducted at RT (where expected tau values are in the range of 30s) or at 37{degree sign}C (one would expect taus of around 10 s in this case for Syp-pH)? I ask the authors to carefully check and possibly re-analyze their datasets.</p></disp-quote><p>This is indeed a mistake. We thank the reviewer for flagging this miscalculation. Our original Matlab script used for calculating the tau value contained an error and the datasets were normalized twice by mistake. We now reanalyzed the data and the corresponding figures and texts have been updated. Our conclusion that Rab10 KD does not affect SV endocytosis remains unchanged since the difference in tau between the control (28.5 s) and Rab10 KD (32.8 s) suffered from the same systematic error and were/are not significantly different.</p><disp-quote content-type="editor-comment"><p>(6) How many times was the proteomics experiment shown in Figure 3 conducted? I noticed that the data in panel H missed statistical analysis and error bars. Given the typical variation in these experiments, I suggest to only include data for proteins identified in at least 3 out of 4 experimental replicates.</p></disp-quote><p>We agree that this information has not been clear. We have now explained replication in the Methods section (p. 42, l. 879-885). In brief, the proteomics experiment presented in Fig 3 was conducted with two independent cultures (‘biological replicates’), hence, formally only two independent observations. For each biological replicate, we performed four technical replicates. For our analysis, we only included peptides that were consistently detected across <italic>all</italic> samples (not only three as this reviewer suggests). Proteins in Panel H are ER-related proteins that are significantly different from control neurons with an adjusted FDR ≤ 0.01 and Log2 fold change ≥ 0.56. The primary purpose of our proteomics experiments was to generate hypotheses and guide subsequent experiments and the main findings were corroborated by other experiments presented in the manuscript.</p><disp-quote content-type="editor-comment"><p>Minor:</p><p>(7) Figure 2 - supplement 3 and Figure 4 - supplement 3 are only mentioned in the discussion. The authors should consider referring to these data in the results section.</p></disp-quote><p>This is a valid point. We have now added a new statement “Moreover, only 10% of DCVs co-transport with Rab10” in the Results (p. 6-7, l. 162-164).</p><disp-quote content-type="editor-comment"><p>(8) Where is the pHluorin data shown in Figure 1 bleach-corrected? If so, this should be stated somewhere in the Ms. Moreover, the timing of the NH4Cl pulse should be indicated in the scheme in panel I.</p></disp-quote><p>We thank the reviewer for pointing these omissions out. We have now included information about the timing of NH4Cl pulse in panel I. We did not do bleach-correction for the pHluorin data shown in Figure 1. It has been shown that pHluorin is very stable with a bleaching rate in the alkaline state of 0.06% per second and 0.0024% per second in the quenched state (Balaji and Ryan, 2007). Indeed, we did not observe obvious photobleaching in the first 30s during our imaging as indicated by the average trace of pHluorin intensity in panel I.</p><disp-quote content-type="editor-comment"><p>(9) Page 3/ lines 59-60: &quot;...strongest inhibition of neuropeptide accumulation...&quot;. What is probably meant is &quot;...strongest inhibition of neuropeptide release&quot;.</p></disp-quote><p>We agree this statement is unclear. Sasidharan et al used a coelomocyte uptake assay as an indirect readout for DCV release. The ‘strongest inhibition of neuropeptide accumulation’ in coelomocytes in Rab10 mutant indicates DCV fusion deficits. We have now replaced the text with “Rab10 deficiency produces the strongest inhibition of neuropeptide release in <italic>C. elegans</italic>” to make it more clear.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>I strongly recommend the publishing of this study as a VOR with minor comments directed to the authors.</p><p>(1) In Figure 4, the authors should include examples of tubular ER at the synapse, especially as this is an interesting point discussed in ln 226-229. Are there noticeable changes in the ER-mitochondria contacts at the synaptic boutons?</p></disp-quote><p>We agree that examples of tubular ER at the synapse would improve the manuscript. We have now replaced the Figure 4A with such examples. We found it challenging to quantify ER-mitochondria contacts based on the electron microscopy (EM) images we currently have. The ER-mitochondria contact sites are quite rare in the cross-sections of our samples, making it difficult to perform a reliable quantitative analysis.</p><disp-quote content-type="editor-comment"><p>(2) The limited impairment of calcium-ion homeostasis in Rab10 KD neurons is very interesting. Would the overexpression of Rab10T23N mimic the effect of a KD scenario? Is there a separation of function for Rab10 in calcium homeostasis vs. the regulation of protein synthesis?</p></disp-quote><p>This is an interesting possibility. We tested this and expressed Rab10T23N in a new series of experiments. These data are presented as a new Figure 5 in the revised manuscript (p. 29). We observed that Ca2+ refilling after caffeine treatment was delayed to a similar extent in Rab10T23N-expressing and Rab10 KD neurons. While impaired Ca2+ homeostasis may affect protein synthesis through ER stress or mTORC1 activation, our findings indicate otherwise in Rab10 KD neurons. First, ATF4 levels, a marker of ER stress, were unaffected in Rab10 KD neurons. This indicates that any ER stress present is minimal or insufficient to significantly impact protein synthesis through this pathway. Second, we did not observe significant changes in mTORC1 activation in Rab10 KD neurons as indicated by a normal pS6K1 phosphorylation (see above). Based on these observations, we conclude that Rab10's roles in calcium homeostasis and protein synthesis are most likely separate.</p><disp-quote content-type="editor-comment"><p>(3) The authors indicate that the internal release of calcium ions from the ER has no effect on DCV trafficking and fusion without showing the data. It is important to include this data as the major impact of the study is the dissecting of the calcium effects in mammalian neurons from the previous studies in invertebrates.</p></disp-quote><p>We agree this is an important aspect in our reasoning. We are submitting the related manuscript on internal calcium stores to BioRVix. The link will be added to the consolidated version of our manuscript</p><disp-quote content-type="editor-comment"><p>(4) The distinction between Rab3 and Rab10 co-trafficking on DCVs should be reported in the Results (currently, Figure 2 - supplement 3 is only mentioned in the Discussion) as it helps to understand the effects on DCV fusion.</p></disp-quote><p>We agree. We now added a new statement “Moreover, only 10% of DCVs co-transport with Rab10” in the Results (p. 6, l. 162-163).</p><p>Reference:</p><p>Balaji, J., Ryan, T.A., 2007. Single-vesicle imaging reveals that synaptic vesicle exocytosis and endocytosis are coupled by a single stochastic mode. Proceedings of the National Academy of Sciences 104, 20576–20581. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.0707574105">https://doi.org/10.1073/pnas.0707574105</ext-link></p><p>Brunner, J.W., Lammertse, H.C.A., Berkel, A.A. van, Koopmans, F., Li, K.W., Smit, A.B., Toonen, R.F., Verhage, M., Sluis, S. van der, 2022. Power and optimal study design in iPSC-based brain disease modelling. Molecular Psychiatry 28, 1545. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41380-022-01866-3">https://doi.org/10.1038/s41380-022-01866-3</ext-link></p><p>Emperador-Melero, J., Huson, V., van Weering, J., Bollmann, C., Fischer von Mollard, G., Toonen, R.F., Verhage, M., 2018. Vti1a/b regulate synaptic vesicle and dense core vesicle secretion via protein sorting at the Golgi. Nat Commun 9, 3421. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-018-05699-z">https://doi.org/10.1038/s41467-018-05699-z</ext-link></p><p>Granseth, B., Odermatt, B., Royle, S.J., Lagnado, L., 2006. Clathrin-Mediated Endocytosis Is the Dominant Mechanism of Vesicle Retrieval at Hippocampal Synapses. Neuron 51, 773–786. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.neuron.2006.08.029">https://doi.org/10.1016/j.neuron.2006.08.029</ext-link></p><p>Ivanova, D., Dobson, K.L., Gajbhiye, A., Davenport, E.C., Hacker, D., Ultanir, S.K., Trost, M., Cousin, M.A., 2021. Control of synaptic vesicle release probability via VAMP4 targeting to endolysosomes. Science Advances 7, eabf3873. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/sciadv.abf3873">https://doi.org/10.1126/sciadv.abf3873</ext-link></p><p>Kwon, S.E., Chapman, E.R., 2011. Synaptophysin Regulates the Kinetics of Synaptic Vesicle Endocytosis in Central Neurons. Neuron 70, 847–854. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.neuron.2011.04.001">https://doi.org/10.1016/j.neuron.2011.04.001</ext-link></p><p>Reshetniak, S., Fernández-Busnadiego, R., Müller, M., Rizzoli, S.O., Tetzlaff, C., 2020. Quantitative Synaptic Biology: A Perspective on Techniques, Numbers and Expectations. International Journal of Molecular Sciences 21, 7298. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms21197298">https://doi.org/10.3390/ijms21197298</ext-link></p></body></sub-article></article>